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Lori A. Catalano 
COMPARING ENGAGEMENT IN ADVANCE CARE PLANNING BETWEEN 
STAGES OF HEART FAILURE 
Heart failure is a terminal disease with an unpredictable trajectory.  Family 
members of patients with heart failure are often called upon to make decisions about 
treatment and end of life care, sometimes with little guidance as to the patients’ wishes.  
Advance care planning (ACP) is an ongoing process by which patients make decisions 
about their future healthcare.  Only about one-third of patients with heart failure have 
participated in ACP, which is a similar percentage to the overall population.  Despite 
increased focus on ACP and interventions to improve it, the rates of ACP in the 
population remain relatively unchanged.  There is a need to develop interventions that are 
targeted based on patient engagement in the process rather than the existing broad-based 
interventions.  
The purpose of this dissertation study is to examine the relationship between the 
American Heart Association stage of heart failure and readiness to engage in advance 
care planning.  The study consisted of mailed surveys that consisted of demographic 
questionnaires and the Advance Care Planning Engagement Survey.  Engagement was 
analyzed in relation to heart failure stage, heart failure class, comorbidities, perception of 
health status, recent hospitalizations, making healthcare decisions for others, and 
demographic variables.  The results demonstrated that although there was no significant 
association between heart failure stage or class and engagement in advance care planning, 
there were significant associations between medical comorbidities and advance care 
planning engagement.  Other significantly associated participant characteristics included 
viii 
age, gender, education, ethnicity, and income.  Findings suggest that people with multiple 
comorbid conditions will be more likely to be ready to engage in ACP than those with 
fewer health conditions.  The results from this study will contribute to the development of 
strategies to improve advance care planning that are targeted based on engagement level. 
   
Susan Hickman, PhD, Chair 
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CHAPTER 1 
THE NATURE OF THE STUDY 
 This study was designed to explore advance care planning in patients with heart 
failure.  The main objective of this study was to examine the relationship between the 
American College of Cardiology Foundation/American Heart Association (ACCF/AHA) 
stage of heart failure, New York Heart Association (NYHA) class of heart failure, and 
engagement in advance care planning, as measured by the Advance Care Planning 
Engagement Survey (ACPES) (Sudore et al., 2017).  This descriptive correlational study 
also examined patient characteristics that may predict engagement in advance care 
planning, including: gender; age; race/ethnicity; marital status; income; education; 
religion; health status; health literacy; and comorbid health conditions.  Findings from 
this study provide information regarding factors that are associated with engagement in 
advance care planning.  Ultimately, this research will be used to inform future research to 
develop targeted interventions to increase rates of advance care planning in patients with 
heart failure. 
Background and Significance 
 It is estimated that approximately 5.7 million people in the United States are 
currently diagnosed with heart failure, with an additional 700,000 people newly 
diagnosed each year (Mozzafarian et al., 2016).  Heart failure is one of the leading cause 
of hospitalizations in people aged 65 years or older and contributes to one of every nine 
deaths (Benjamin et al., 2017).  The disease cost approximately $31 billion annually in 
healthcare costs and lost employment days in 2012, and this cost is expected to increase 
to approximately $70 billion by 2030 (Heidenreich et al., 2013).   
2 
A severe, insidious disease, heart failure (HF) is a terminal syndrome in which the 
heart is unable to meet the oxygenation demands of the body due to either structural or 
functional defects.  Approximately one-half of those with heart failure will die within five 
years of diagnosis, typically as a result of sudden death from a lethal dysrhythmia 
(Mozzafarian et al., 2016).  The remainder will experience a slow decline in health status 
over many years.  Treatment of heart failure varies based on staging from the American 
College of Cardiology Foundation and the American Heart Association (ACCF/AHA), 
which leads to the need to reevaluate a patient’s status on a regular basis to determine the 
appropriate, evidence-based therapy (Hammond et al., 2016).  The American Heart 
Association periodically publishes clinical guidelines that recommend evidence-based 
therapy based on ACCF/AHA stage, including provision of advance care planning.  The 
2013 guidelines recommended that all cardiologists and other practitioners be 
comfortable with advance care planning in order to encourage it in their patients with 
heart failure (Yancy et al., 2013).  This includes discussion of treatment options based on 
patient status and also consultations to palliative care if available (Yancy et al., 2013). 
Advance care planning (ACP) is an ongoing process by which patients make 
decisions about their future healthcare based on their personal values, life goals, and 
preferences (Sudore et al., 2017b; Sudore et al., 2013).  This process includes discussion 
of patient values, goals, and preferences with both family and healthcare providers. It 
may also include selection of a surrogate decision-maker (SDM) and the completion of 
advance directives (AD) (Sudore et al., 2017b; Piemonte & Hermer, 2013; Rogne & 
McCune, 2014; Sudore et al., 2013).  ACP was formally addressed by the Institute of 
Medicine (IOM) in its publication, “Dying in America,” in which the IOM panel noted 
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the need to “develop standards for clinical-patient communication and ACP that are 
measurable, actionable, and evidence based (IOM, 2014, p. 3).  These standards would 
include routine discussion of prognosis, decision-making preferences, patient goals of 
care, and patient wishes for family involvement (Bernacki & Block, 2014).  The Joint 
Commission also requires evidence of advance care planning to be reported as part of a 
hospital’s advanced HF certification (TJC, 2016).   
Despite the endorsement of these organizations, approximately two-thirds of 
American adults have never engaged in advance care planning, and this proportion has 
remained relatively stable over the last several years (Benson & Aldrich, 2012; Stevenson 
& O’Donnell, 2015; Yadav et al., 2017).  This number has been shown to be even lower 
in patients with heart failure. In 2012, one study found that 41% of patients with heart 
failure had ADs (Dunlay, Swetz, Mueller, & Roger, 2012), but another study in 2015 
found that only 12.7% of these patients had ADs (Butler et al., 2015).  More recently, 
Yadav et al. (2017) found that 38.2% of adults with chronic illnesses had completed 
advance directives, but did not examine the rates of completion by specific disease 
process.   
Statement of the Problem 
 Advance care planning has been shown to have a variety of benefits, including 
increased likelihood others will know and follow the patient’s healthcare preferences, 
especially at the end of life (Detering et al., 2010; Johnson, Kerridge, Butow, & 
Tattersall, 2017; Sudore et al., 2013).  It also is associated with decreased use of intensive 
medical therapies and increases the use of palliative interventions and hospice (Houben et 
al., 2014; Khan et al., 2014; Wright et al., 2008).  Despite these benefits, many older 
4 
adults, including those with heart failure, have not participated in advance care planning 
to the extent that it is able to inform their healthcare; while they may have completed 
advance directives, the majority of older adults have not discussed their preferences with 
providers or family (Bond et al., 2018; Schickedanz et al., 2009).  Several interventions 
have been developed to improve participation in ACP, but these interventions require an 
individual to be ready to engage in the process.  This readiness to engage may depend on 
a variety of factors, including socioeconomic variables, a patient’s other illnesses, and 
life events (Fried et al., 2010; Sudore et al., 2013). 
One way to target future interventions is to determine a patient’s stage of change 
related to engaging advance care planning.  The Trans-Theoretical Model (TTM), 
introduced in 1986, describes change as a cyclical process containing stages through 
which people progress or regress (Prochaska & DiClemente, 1986).  These stages of 
change are a way people adopt healthy behaviors; they include precontemplation, 
contemplation, preparation, action, and maintenance (Prochaska & DiClemente, 1986).  
These stage names reflect how a person can transition from a lack of knowledge or 
concern about a health behavior through the point of actively changing a behavior.  
Figure 1 (based on Prochaska & DiClemente, 1986) illustrates the stages of change based 
on the TTM.  Engagement in ACP is one such health behavior to which researchers can 
apply the TTM.  Because all health behaviors can be revisited, it is shown as a circle.   
When applying the TTM to ACP, it is necessary to view ACP as a series of 
connected discrete behaviors rather than just one.  ACP consists of discussing values and 
goals of care with loved ones, surrogate decision-makers, and providers (Sudore et al., 
2013).  It also includes completion of advance directives such as living wills and health 
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care proxy appointments (Sudore et al., 2013).  A person’s stage of change may vary 
depending on the behavior (Fried et al., 2010). Thus, a person may have discussed values 
and goals of care with loved ones, and be in the action stage for that behavior, but not yet 
ready to discuss them with providers, and be in the precontemplation stage for that 
behavior.  Definitions of the stages and related ACP behaviors are in Table 1(based on 
Prochaska & DiClemente, 1986 and Fried et al., 2010).  Figure 2 illustrates examples of 
the different stages of change for completing a living will, one of the series of discrete 
ACP behaviors, taken from Fried et al. (2010). 
Figure 1: Trans-Theoretical Model (TTM) of Behavioral Change 
 
 
 
 
 
Table 1: Definitions and ACP Behaviors in Trans-Theoretical Model 
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Stage Definition Relevant ACP Behaviors 
Precontemplation  No intention of changing 
behavior; possibly unaware of 
need for change 
No associated behaviors; 
patient has not thought about 
ACP 
Contemplation Aware of need to change 
behavior, but no commitment 
to take action 
Patient is thinking about 
engaging in some aspect of the 
ACP process in the next six 
months 
Preparation Intention to take action in the 
next thirty days 
Patient is thinking about 
engaging in some aspect of the 
ACP process in the next thirty 
days 
Action Actual modification of the 
behavior or environment 
Patient is speaking to loved 
ones and/or providers about 
values and goals of care; patient 
is documenting such goals of 
care.  These behaviors are 
either actively ongoing or were 
done in the previous six 
months. 
Maintenance Stabilization of the new 
behavior over a period of time 
Patient has spoken to loved 
ones and/or providers about 
values and goals of care and has 
documented such discussions.  
A surrogate decision-maker has 
been formally appointed.  
These behaviors have occurred 
more than six months ago. 
Permanent Exit 
or Termination 
No risk of returning to the old 
behavior; new behavior is 
permanent 
Not applicable for many health 
behaviors.  In ACP, may occur 
when patient loses capacity to 
engage in ACP and SDM 
begins to make decisions. 
Relapse Reversion back to previous 
unhealthy behavior; may occur 
at any time 
May not occur in ACP or may 
reflect a change in health status 
that causes a need to revisit the 
cyclical process 
Key: ACP = advance care planning; SDM = surrogate decision maker. 
Figure 2: Algorithm for Living Will Completion, Showing Different Stages of Change  
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Through their research, Sudore and colleagues determined that four behavioral 
change processes affected a person’s engagement in ACP, including the person’s stage of 
change under the TTM (Fried et al., 2010; Sudore & Fried, 2010; Sudore et al., 2013).  
These processes include knowledge, contemplation, self-efficacy, and readiness (Sudore 
et al., 2013).  The processes are further discussed in Chapter 2.  The four behavioral 
change processes influence each of the four ACP domains of decision making, quality of 
life, flexibility for surrogates, and asking questions and move people along the stages of 
change from the TTM model (Sudore et al., 2013).  Figure 3 shows the relationship 
between the behavioral change processes and the actions people take within the ACP 
domains that are part of the health behavior change.  Engagement in each of the four 
identified domains is affected by a person’s knowledge of the behavior, contemplation of 
the behavior, inherent self-efficacy, and readiness to engage in the behavior.  The end 
result in each domain is a series of actions that include choosing a surrogate and asking 
them, discussing goals of care and values with the surrogate and the provider, and asking 
providers questions about treatment and alternatives.  Throughout this series of processes 
8 
and actions, the healthcare provider guides the patient by supplying information about 
health status, disease trajectory, and available treatment options.  As the patient’s 
condition changes, the provider must update the patient on the potential changes to the 
treatment plan in order to assist the patient in making informed decisions. 
Figure 3: Interaction of ACP Domains, Behavioral Processes, and Actions 
 
Findings from this research could assist in determining the association between 
engagement in ACP and various predictor variables, including heart failure stage as 
determined by the American College of Cardiology Foundation and American Heart 
Association (ACCF/AHA), heart failure class as determined by the New York Heart 
Association (NYHA), patient perception of health status, recent hospitalizations, and 
sociodemographic variables.  Understanding which predictor variables affect a person’s 
stage of change will assist in future research to develop interventions based on stage of 
change, rather than interventions that are very general.  If interventions are based on the 
TTM’s stages of change, they may be more successful with patients with heart failure.   
The frequency of occurrence of discrete advance care planning behaviors such as 
appointing a healthcare proxy, discussing healthcare preferences with the proxy and 
providers, and completing advance directives has not been well described in the heart 
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failure population.  Percentages of heart failure patients with advance directives range 
from 12.7% (Butler et al., 2015) to 41% (Dunlay, Swetz, Mueller, & Roger, 2012), but 
these results do not distinguish between living wills and appointment of surrogates, nor 
do they include discussion of preferences with providers and proxies.  Recently, Yadav et 
al. (2017) found that 38.2% of adults with chronic illnesses had completed advance 
directives, as opposed to only 32.7% of healthy adults.  When divided into type of 
advance directive, Yadav noted that 33.4% of all patients had appointed a surrogate 
decision-maker.   
Additionally, no studies to date have been focused on the relationship between 
heart failure stage or class and engagement in advance care planning.  The current study 
will inform future research by determining how disease stage and other variables impact 
level of engagement.  If relationships between HF stage and engagement in ACP are 
found, it may guide the development of targeted interventions focused on heart failure 
stage or class.  The goal of these targeted interventions would be to have individuals 
participate in ACP, which would then increase the ability of healthcare providers to 
provide care that is consistent with an individual’s preferences. 
The current research is based upon the TTM model, but the model to be tested 
adds in certain patient characteristics and experiences that could affect a person’s stage of 
change as related to ACP.  These characteristics are potential predictor variables in the 
model and include health variables such as ACCF/AHA heart failure stage; NYHA heart 
failure class; comorbidities; perception of health status; personal experiences such as 
recent hospitalizations and making healthcare decisions for others; and sociodemographic 
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characteristics such as age, gender, ethnicity, marital status, income, education level, and 
health literacy.  Figure 4 illustrates the model for the currently proposed research. 
Figure 4: Factors Affecting Engagement in ACP 
Predictor Variables  Behavioral Change Processes  Engagement in ACP              
   
                               
 
 
 
Research Aims 
 The specific aims and research questions of the study were: 
Specific Aim 1: To describe advance care planning engagement in patients with heart 
failure. 
 Research questions for Specific Aim 1 included: 
1A.  What are the characteristics of patients who are participating in this 
study of advance care planning? 
1B.  What percentage of patients in this study report having appointed a 
surrogate decision-maker for health care decisions? 
Health Variables: 
• ACCF/AHA HF 
Stage 
• Comorbidities 
• Health perception 
 
Personal Experiences: 
• Recent 
hospitalizations 
• Making healthcare 
decisions for others 
 
Sociodemographics: 
• Age 
• Gender 
• Ethnicity 
• Marital status 
• Income 
• Education level 
• Health literacy 
 
 
Knowledge 
 
Contemplation 
 
Self-efficacy 
 
Readiness  
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1C.  What percentage of patients in this study report discussions of values 
and goals of care with surrogate decision-makers? 
1D.  What percentage of patients in this study report discussions of values 
and goals of care with healthcare providers? 
1E.  What percentage of patients in this study report having completed 
advance directives? 
Specific Aim 2: To explore the association between patient engagement in advance care 
planning and ACCF/AHA heart failure stage; NYHA heart failure class; comorbidity 
index; patient perception of health status; recent hospitalizations; and the 
sociodemographic variables of age, gender, ethnicity, marital status, income, education, 
and religiosity. 
Research questions for Specific Aim 2 include: 
2A. What is the strength of the association between engagement in 
advance care planning and ACCF/AHA heart failure stage? 
2B. What is the strength of the association between engagement in 
advance care planning and NYHA heart failure class? 
2C. What is the strength of the association between engagement in 
advance care planning and patient comorbidities? 
2D. What is the strength of the association between engagement in 
advance care planning and patient perception of health status? 
2E. What is the strength of the association between engagement in 
advance care planning and any recent hospitalization? 
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2F. What is the strength of the association between engagement in 
advance care planning and making healthcare decisions for others? 
2G. What is the strength of the association between engagement in 
advance care planning and the sociodemographic variables of age, gender, 
ethnicity, marital status, income, education, religion, and health literacy? 
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CHAPTER 2 
LITERATURE REVIEW AND CONCEPTUAL FRAMEWORK 
 Chapter 1 presented the nature of the current study including a statement of the 
problem, the study purpose, specific aims and hypotheses, the conceptual model, and 
conceptual and operational definitions.  This chapter will provide an overview of heart 
failure as the disease process of interest; the current scientific evidence regarding ACP, 
including that related specifically to heart disease; an overview of both Prochaska’s 
Trans-Theoretical Model (TTM) and Sudore’s (2017) advance care planning engagement 
model; and an explanation of the proposed conceptual model.  
Overview of Heart Failure 
 Heart failure is a complex, multifactorial condition that affects over five million 
adults in the United States.  It is characterized by the heart’s inability to sustain an output 
that is sufficient to meet the needs of the body.  Heart failure is a contributing factor to 
over ten percent of all U.S. mortalities (Heidenreich et al., 2013; Saour, Smith, & Yancy, 
2017).  Risk factors for heart failure include family history; hypertension; maladaptive 
health behaviors such as smoking, sedentary lifestyle, and an atherogenic diet (i.e., high 
in cholesterol and saturated fats); age; male gender; and cardiac defects, with most 
patients having several risk factors (Brashers, 2014).  Diagnosis is typically prompted by 
patient-reported symptoms, such as exercise intolerance, fatigue, fluid retention, and 
shortness of breath (Brashers, 2014).  Notable signs will include dependent edema, 
crackles indicative of pulmonary edema, and jugular venous distention (Hammond et al., 
2016).  Diagnostic testing such as echocardiography and right-sided cardiac angiograms 
are used to confirm the suspected diagnosis (Hammond et al., 2016). 
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Classes and Stages 
 There are two approaches to categorizing HF.  The American College of 
Cardiology Foundation and American Heart Association (ACCF/AHA) describe stages of 
HF that focus on the development and progression of the disease and can be used to 
describe both individuals and populations (Yancy et al., 2013).  Staging is done by the 
healthcare provider and includes objective consideration of structural changes in the heart 
and ejection fraction (EF).  Possible structural changes include hypertrophy or dilation of 
heart chambers and valvular dysfunction.  EF, the percentage of blood volume ejected 
from the left ventricle with each contraction, is also examined and contributes to the 
staging.  Measurement of both structural changes and EF can be done through non-
invasive testing such as an echocardiogram.  Once an individual has progressed to a later 
stage, that progression is irreversible.  Progression along the stages is linked to increased 
morbidity rates over a 5-year period. 
The New York Heart Association (NYHA) describes classes of HF that are based 
upon patient-reported symptom severity and individual functional capacity (Yancy et al., 
2013).  It is a more subjective assessment and can change frequently over short periods of 
time, with patients fluctuating between classes.  However, the NYHA is still widely used 
by cardiology providers in both clinical practice and research and for the determination of 
eligibility of healthcare services such as visiting nurses, supplemental oxygen, and 
cardiac rehabilitation because it is an independent predictor of mortality (Yancy et al., 
2013).  A comparison of the two classifications is shown in Table 2.   
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Table 2: Comparison of Stages and Classes of Heart Failure  
ACCF/AHA Stages of Heart Failure NYHA Functional Classification 
A At high risk for HF but without 
structural heart disease or 
symptoms of HF 
None  
B Structural heart disease but 
without signs or symptoms of HF 
1 No limitation of physical 
activity. Ordinary physical 
activity does not cause symptoms 
of HF. 
C Structural heart disease with prior 
or current symptoms of heart 
failure 
1 No limitation of physical 
activity. Ordinary physical 
activity does not cause symptoms 
of HF. 
2 Slight limitation of physical 
activity. Comfortable at rest, but 
ordinary physical activity results 
in symptoms of HF. 
3 Marked limitation of physical 
activity. Comfortable at rest, but 
less than ordinary activity causes 
symptoms of HF. 
D Refractory HF requiring 
specialized interventions 
4 Unable to carry on any physical 
activity without symptoms of 
HF, or symptoms of HF at rest. 
Key: ACCF = American College of Cardiology Foundation; AHA = American Heart 
Association; HF = heart failure; NYHA = New York Heart Association. 
 
Patients diagnosed with heart failure are staged based on the ACCF/AHA criteria 
(A, B, C, or D). Treatment options are individualized based on the stage, the ejection 
fraction, and any comorbidities (Hammond et al., 2016; Yancy et al., 2013).  For patients 
in Stage A, treatment is focused on recognizing and treating precipitating conditions such 
as hypertension and hyperlipidemia, and controlling comorbid conditions such as 
diabetes, obesity, and tobacco cessation (Yancy et al., 2013).  Diagnosis of Stage A is 
based on these pre-conditions because there are no overt signs or symptoms.  Once 
patients have progressed to Stage B, pharmacotherapy is used to prevent symptoms and 
further structural deterioration; management of the comorbid conditions also continues 
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(Yancy et al., 2013).  Patients in this stage are still often undiagnosed, because they have 
few or no functional limitations.  Stage C patients require more intense pharmacotherapy; 
implanted devices such as biventricular pacemakers and automatic internal cardiac 
defibrillators are also likely indicated at this time (Saour, Smith, & Yancy, 2017; Yancy 
et al., 2013).  Finally, end-stage patients fall into Stage D.  At this point in the disease 
process, comorbid conditions, age, and patient preferences will determine whether more 
intensive treatments are selected; such treatments range from intravenous infusions of 
supportive medications to left ventricular assistive devices to cardiac transplantation 
(Hammond et al, 2016; Yancy et al., 2013).  NYHA class is also used to determine the 
effectiveness of treatment because the classifications require consideration of both patient 
symptoms and functional limitations (Yancy et al., 2013). 
Trajectory of Heart Failure 
 Heart failure is an unpredictable condition, with approximately 50 percent of 
those diagnosed dying within five years (Saour, Smith, & Yancy, 2017).  The other 50 
percent experience a slow but steady decline with periods of stability and exacerbations.  
Prediction of a patient’s progression through the stages of the disease involves 
consideration of multiple factors, including: functional tests such as oxygen consumption; 
serum markers such as natriuretic peptide levels and creatinine levels; response to 
medications and other interventions; and comorbid conditions, making it difficult for 
providers to estimate impending mortality (Kheirbek et al., 2013).  These exacerbations 
often require repeated hospitalizations and, with later stages, often bring patients to life-
or-death situations.  Because of the availability of extensive treatment options, patients 
are usually stabilized after these exacerbations, making long-term prognoses difficult.  
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Additionally, many patients’ comorbid conditions such as diabetes mellitus and chronic 
kidney disease will hasten progression along the heart failure trajectory (Ahluwalia et al., 
2012). 
Costs of Heart Failure 
 Heart failure is one of the most expensive chronic conditions in the U.S., with 
2012 direct costs exceeding $21 billion, and 2030 direct costs estimated to increase to 
$53 billion.  Adding in the indirect costs, such as sick days and loss of productivity, 
brings the total estimated cost to $70 billion in 2030 (Heidenreich et al., 2013).  This 
estimate assumes that the prevalence of heart failure remains the same and that the 
increase in technological costs remains stable.  Twenty-five percent of Medicare 
spending on heart failure is spent during the last year of life, and these costs are 
increasing because of the increased numbers of patients with some degree of heart failure 
and increases in technological advances (Chen-Scarabelli et al., 2015).   
The Joint Commission and Other Recommendations 
Many regulatory bodies issue recommendations for treatment of heart failure, 
including The Joint Commission (TJC), the AHA, and the ACCF.  These treatment 
recommendations include not only medications and devices, but also recommendations 
for social services, counseling, and advance care planning.  These recommendations are 
published in the form of reportable performance measures or official treatment 
guidelines. 
TJC issues standardized reportable performance measures for facilities to obtain 
Advanced Certification in Heart Failure (ACHF), developed to emphasize transition of 
care for the heart failure patient.  Facilities are required to collect data on six measures in 
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order to obtain and maintain the ACHF from TJC, including ACHF-04, “Discussion of 
Advance Directives/Advance Care Planning;” and ACHF-05 “Advance Directive 
Executed” (TJC, 2015).  Discussion of advance directives/advance care planning requires 
that there be documentation of at least one discussion of either advance directives or 
advance care planning in the medical record (TJC, 2015).  The execution requirement, 
ACHF-05, requires that there be documentation of the execution of an advance directive 
in the medical record unless the patient was discharged to hospice or is designated as 
receiving only comfort care measures (TJC, 2015).   
The AHA also issues a set of guidelines, “Get with the Guidelines” (GWTG) that 
are designed to ensure evidence-based care for patients with heart failure.  GWTG 
addresses a series of evidence-based care guidelines that were formerly part of TJC’s 
Core Measures for Congestive Heart Failure, including certain medications to be 
prescribed, rehabilitation consultations, and the presence of an advance care plan or 
surrogate decision-maker appointment in the medical record (AHA, 2013).  Beginning in 
2019, the AHA and TJC will collaborate for all heart failure certification to ensure 
standardized, evidence-based care for all patients diagnosed with heart failure; this 
certification will combine the data collection described above and participation in the 
GWTG program (TJC, 2018). 
Finally, the AHA, the ACCF, and the Heart Failure Society of America (HFSA), 
issue guidelines for the management of heart failure.  The 2016 and 2017 guidelines 
made no changes to the 2013 guideline on care coordination, which includes a 
recommendation that cardiologists, advanced practice nurses, and other members of the 
healthcare team should be familiar with advance care planning in order to “enhance the 
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overall quality of decision making and integrated care for these patients, regardless of the 
. . . therapy selected” (Yancy et al., 2013). 
Advance Care Planning 
When individuals are able to communicate their goals of care with their 
healthcare providers and family, treatment can be formulated based upon those goals.  If 
individuals are unable to communicate their goals, however, then families and providers 
are often called upon to make decisions without sufficient knowledge of the patient’s 
goals of care.  Advance care planning (ACP) is a process of planning future healthcare in 
order to ensure that patients’ preferences are followed in the event that they are unable to 
make their own decisions (Sudore et al., 2017b; Sudore et al., 2013).   
Advance Care Planning Documentation Tools 
There are a variety of tools used to document a person’s preferences for future 
healthcare elicited through an ACP discussion.  These tools range from provider orders 
that are initiated at each hospital visit to enduring documents that reflect the person’s 
preferences of care in particular situations, such as living wills and documentation of 
healthcare proxies. 
Advance directives.  Living wills and healthcare proxies (also known as 
healthcare powers of attorney) are the most common forms of advance directives relevant 
for care at the end of life.  Living wills are documents that list certain medical situations 
and the patients’ preferences about what to do in those situations; Living wills typically 
address situations such as persistent comas, cardiac arrest, and respiratory arrest (Levi & 
Green, 2010).  Healthcare proxies, sometimes referred to as surrogate decision-makers, 
are persons appointed by a patient to make healthcare decisions in the event that a patient 
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is unable to do so (Levi & Green, 2010).  The effects of advance directives, including 
benefits and barriers, will be discussed in a later section. 
Code status orders.  Code status orders address whether or not a person wants to 
be resuscitated upon cardiac or respiratory arrest and are one way to document a person’s 
preferences for healthcare (Yuen, Reid, & Fetters, 2011).  The most common of these are 
do-not-resuscitate (DNR or DNAR) orders, which mandate that the patient will not 
receive medications, cardiopulmonary resuscitation, or intubation.  Patients may dictate 
certain alterations to them, including requesting all resuscitation measure other than 
intubation (DNI, or do-not-intubate order).  These changes are based upon patient 
preferences after discussion with a healthcare provider. Many studies have shown the 
effects of a DNR order.  These studies focus on patients not only in hospitals, but also 
nursing homes, and overall show a decrease in the administration of life-sustaining 
treatment, not limited to cardiopulmonary resuscitation.  Studies have revealed decreases 
in the use of mechanical ventilation, inotropic and vasopressive medications, and dialysis 
(Chang et al., 2010; Huang et al., 2010; Sinuff et al., 2004).  Patients from nursing homes 
with various diagnoses, including cognitive impairment, acute respiratory illnesses, and 
other chronic diseases, have lower rates of hospitalization when they have a DNR order 
on file (Gozalo et al.., 2011; Miller, Gozalo, & Mor, 2001; Rector et al., 2005; Teno et 
al., 2011; Zheng et al., 2011; Zweig et al., 2004).   
Physician Orders for Life-Sustaining Treatment (POLST).  The POLST is a 
relatively new tool for documenting patient preferences for care and address situations 
where a patient has determined he or she does not want life-sustaining treatment.  
Designed for those with serious illnesses, POLST address similar areas to those 
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addressed by a living will, including preferences for CPR and artificial nutrition, but also 
address whether or not a patient wants hospitalization or antibiotics in given situations 
(Hickman et al., 2010).  These orders, unlike facility-specific DNR orders, follow a 
person from home to all healthcare facilities, including hospitals and nursing homes.  The 
orders are outcome-neutral, meaning that they can reflect a person’s preference either to 
avoid life-sustaining treatment or to accept it.  They are also true medical orders, unlike a 
living will, and thus do not require additional interpretation (Hickman et al., 2010).   
Since its inception, POLST has been shown to improve both documentation of 
patient wishes and provision of care congruent with these preferences (Hickman, 
Keevern, & Hammes, 2015).  POLST has been shown to be successful in a variety of 
healthcare facilities, including nursing homes and hospices (Hickman et al., 2010; 
Meyers et al., 2004).  Some researchers found, however, that the forms are sometimes 
incomplete and even contradictory, leading to confusion as to a person’s healthcare 
preferences (Clemency et al., 2017).   
The Origin of Advance Care Planning 
Advance directives were the original legal documents that people used to express 
their wishes regarding certain treatment decisions.  The legal support for advance 
directives stemmed originally from bills introduced in Florida and California with the 
support of the Euthanasia Society of America (Sabatino, 2010).  Although the bills were 
defeated in both states for several years, California passed the first law to sanction living 
wills in 1976 (Sabatino, 2010).  Over the next fifteen years, states slowly began passing 
laws allowing advance directives, with all 50 states allowing some form of advance 
directive by 1992.   
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The first major court case to uphold the concept of advance directives was In re 
Quinlan (NJ 1976), where Karen Quinlan, a 21-year-old woman in a persistent vegetative 
state was legally permitted to be removed from a ventilator based on her parents’ wishes.  
Although Quinlan had no documentation about her wishes, the concepts of patient 
autonomy to refuse treatment and surrogate decision-makers for those without decisional 
capacity arose from this case. 
The United States Supreme Court upheld the right to refuse medical treatment in 
Cruzan v. Director, Missouri Department of Health (1990), and also set the stage for 
families and other loved ones to produce evidence in the absence of an advance directive 
that would allow the right to die in certain situations.  Like Karen Quinlan, Nancy Cruzan 
was in a persistent vegetative state.  Her family and friends provided testimony that she 
would not want to live in such a state if she had the capacity to make the choice herself.  
Eventually, her feeding tube was removed, life-supporting care was withdrawn, and she 
died.   
Based on this case, the federal government established the legality of advance 
directives in 1990 with the passage of the Patient Self-Determination Act (PSDA), which 
guarantees patients the right to legally designate a surrogate decision-maker for 
healthcare decisions in the event of patient incapacity (42 U.S.C. §1395cc, §1396a).  
Aimed at ensuring patient autonomy in healthcare decisions and in the creation of 
advance directives, the Act requires healthcare facilities reimbursed by Medicare to 
inform patients of their rights to: (1) make their own healthcare decisions; (2) accept or 
refuse medical treatment; and (3) create advance directives.  The Act does not require 
that a healthcare provider initiate a discussion about advance directives, nor does it 
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require that the facility provide extensive education about advance directives and their 
goals.  It also does not include provisions for reimbursement for such discussions or 
education. 
The goal of advance directives under the PSDA was to preserve individuals’ 
autonomy to make medical decisions when they can no longer speak for themselves 
(Fagerlin & Schneider, 2004).  Ideally, this would have resulted in increased advance 
care planning, resulting in medical treatment and end-of-life care that was more 
congruent with patient wishes.  Since the enactment of this law, however, it is unclear 
whether the percentage of those with advance directives has increased, with one study 
finding that there has been a significant increase (Silveira, Kim, & Langa, 2010), but 
others finding little to no change in the number of people with advance directives (Rao, 
Anderson, Lin, & Laux, 2014; Fagerlin & Schneider, 2004).  Critics of advance directives 
note that several factors may impact the lack of advance directives.  First, people are 
unable to accurately predict their wishes for future medical care because of an inability to 
understand its potential complexities.  While this may be due to a lower health literacy, it 
may also be due to the information provided by the physician in conversations about 
advance directives, or may be due to a patient completing the documents without 
physician input at all (Fagerlin & Schneider, 2004).  Conversations that do occur tend to 
be very short, and tend to deal with potential sequelae of an illness in very general terms 
that prove difficult to use to guide healthcare (Teno et al., 2007; Tulsky, Fischer, Rose, & 
Arnold, 1998).  This lack of discussion could be from a lack of time on the provider’s 
part to thoroughly explain all of the possibilities (Levi & Green, 2010).  People may also 
underestimate the impact debility will have on their lives in the future, and thus may be 
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unable to predict how they would make certain decisions (Fagerlin & Schneider, 2004; 
Levi & Green, 2010).  Once living wills are completed, people struggle to even 
understand what they have placed into writing due to the language used (Fagerlin & 
Schneider, 2004). 
Other reasons that advance directives are not as effective as desired include the 
difficulty of putting complex situations into writing and the translation of the directive to 
actual medical situations.  Living wills typically include a list of situations and treatments 
for a patient to indicate they want or are refusing.  Aside from the problems noted 
regarding understanding terminology and medical complexities, living wills often limit 
their instructions to general terms (Fagerlin & Schneider, 2004; Olick, 2012).  Thus, an 
example may be a question that asks a patient whether or not he wants to have 
mechanical ventilation.  In the actual situation, there will be a variety of factors that 
impact whether or not a patient may have elected for or against mechanical ventilation, 
including the reason, estimated time on a ventilator and the possibility of recovery.  The 
healthcare team and the patient’s appointed or default surrogate decision-maker must 
then extrapolate from the brief information found on the form plus whatever knowledge 
they have extraneous to the form (Fagerlin & Schneider, 2004). 
Finally, there is evidence suggesting that advance directives have little effect on 
the actual decisions made on behalf of patients.  The SUPPORT study, a multi-center, 
five-year study, found that advance directives “failed to improve care or patient 
outcomes” (Connors et al., 1995).  Several years later, Prendergast noted that while 
healthcare providers document the presence of advance directives more often, the 
percentage of patients with them had not increased (2001).  Additionally, those with 
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advance directives often received care that conflicted with their stated directives 
(Jezewski et al., 2005; Scherer et al., 2006).  Even in the presence of formally executed 
advance directives, healthcare providers will often follow conflicting preferences of 
family members at the bedside (Rolnick, Asch, & Halpern, 2017). 
The Shift to Advance Care Planning as a Process 
In response to the failure of advance directives, healthcare providers began 
conceptualizing and promoting the importance of advance care planning as a process 
rather than a document.  This process includes selection of a surrogate decision-maker 
(SDM); discussions with family members, other loved ones, and healthcare providers 
about values and goals of care; and the completion of ADs (Piemonte and Hermer, 2013; 
Rogne & McCune, 2014; Sudore et al., 2013; Sudore et al., 2017).  Although it will 
involve the discussion of end-of-life (EOL) care, ACP has come to be understood as 
being more than just EOL planning, and in fact should be initiated and revisited with the 
progression of any chronic disease (Sudore et al., 2013).  The newest consensus 
definition of ACP notes that it is for all adults “at any age or stage of health” and should 
include discussion of diseases and prognosis, values, life goals, and preferences about 
healthcare (Sudore et al., 2017b).  ACP is not just for older adults; it is “about planning 
for the ‘what ifs’ that may occur across the entire lifespan” (Benson & Aldrich, 2012, p. 
2).   
Researchers in ACP encourage people and providers to begin ACP early in the 
disease process and continue with both disease progression and advances in treatment 
(Rao et al., 2014; Sudore et al., 2013; Sudore et al., 2017b).  ACP includes not only end-
of-life planning, but also extensive discussion about patient goals for the future (Sudore 
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et al., 2013; Sudore et al., 2017a; Sudore et al., 2017b).  Healthcare providers are 
encouraged to extensively discuss the disease process, prognosis, and potential outcomes 
with patients, including their values and wishes regarding invasive treatments, life-
sustaining and supportive care, palliative care, and end-of-life preferences (Ahluwahia et 
al., 2013; IOM, 2014; Sudore et al., 2017b; Weinstock & Johnson, 2011).   
Recently, calls for advance care planning picked up momentum with the 
publication of the Institute of Medicine’s report Dying in America (IOM, 2014).  The 
IOM emphasized the need for person-centered care at the end of life, focusing on the use 
of palliative care and advance care planning.  The committee noted that advance care 
planning, done early in the disease process, will “reduce confusion and guilt among 
family members forced to make decisions about care” (IOM, 2014, p. S1) Included in the 
IOM’s recommendations was the need to “develop standards for clinician-patient 
communication and advance care planning that are measurable, actionable, and evidence 
based” (IOM, 2014, p. S10, 3-56). 
Despite the recognition that advance care planning should be expanded from end-
of-life planning to an ongoing process, two-thirds of U.S. adults have never participated 
in the ACP process, even today (Benson & Aldrich, 2012; Rao et al., 2014; Yadav et al., 
2017).  While the rates of completion of ADs alone do increase with age, the rates of 
ACP discussions with healthcare providers remain low (Brinkman-Stoppelenburg, 
Rietjens, & van der Heide, 2014).   
Effects of Advance Care Planning 
Advance directive completion.  Advance care planning has been shown to have 
many benefits, both psychological and financial.  Although the usefulness of advance 
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directives is debated, advance care planning does increase the rates of completion of both 
living wills and health care powers of attorney (Ahluwalia, Levin, Lorenz, & Gordon, 
2013; Evangelista et al., 2012; Heffner & Barbieri, 2001; Schellinger, Sidebottom, & 
Briggs, 2011; Silveira, Kim, & Langa, 2010).  In a quasi-experimental, one-group pre- 
and post-test study, Evangelista and colleagues (2012) found that the rates of AD 
completion increased from 28% to 47% three months after an intervention focused on 
health perceptions, knowledge of ADs, discussion with family and providers, and 
completion of ADs.  Heffner and Barbieri (2001) focused on patients in multiple cardiac 
rehabilitation programs and found that 49% of those in the intervention group had 
completed living wills and/or DPAHCs, compared to only 38% in the control group.  
Schellinger, Sidebottom, and Briggs (2011) evaluated the Respecting Choices® program 
and found that 94.3% of those who had participated in the program had completed ADs, 
as compared to only 24.8% of those who had received only the usual care.   
Care congruent with patient wishes.  ACP also improves the healthcare team’s 
ability to respect and implement an individual’s goals of healthcare, especially during 
times of decisional incapacity, such as with serious illness exacerbations or at the end of 
life (Silveira et al., 2010).  This may be partially accomplished with a living will, if it 
speaks to the specific situation.  However, ACP goes far beyond the dictates of the living 
will; conversations about goals of care between the patient, family and surrogates, and 
healthcare providers will allow decisions made to be more reflective of the patient’s 
wishes.  Detering and colleagues (2010) used a program similar to the Respecting 
Choices® intervention to encourage ACP, and then later measured whether the patients’ 
end-of-life care had coincided with their wishes by contacting families after death.  This 
28 
was done by comparing documentation of patient wishes in the medical record and 
family statements to the actual care provided prior to death.  Results showed that those 
patients who had engaged in the ACP intervention were significantly more likely (86%) 
to have their end-of-life wishes known and respected than those without the ACP 
intervention (30%) (Detering et al., 2010).   
Other researchers have looked at nursing home residents and congruence of care; 
those residents who regularly discussed advance care planning were significantly more 
likely to have their wishes followed than those who did not (Morrison et al., 2005).  The 
study intervention involved routinely raising the topic of ACP in patient care discussions.  
Only 5% of patients with ACP had treatments that violated their wishes (one was 
hospitalized and one received intravenous antibiotics), where 18% of those without ACP 
had some form of treatment that violated their wishes for treatment (Morrison et al., 
2005).  One similar study, however, did not show a statistically significant difference in 
the congruence of end-of-life care received after an ACP intervention for heart failure 
and renal failure patients (Kirchoff et al., 2012).  The researchers noted that for this 
particular study, patients who received the ACP intervention continued to make their own 
decisions until very near end of life, rather than the decisions being made by a surrogate 
decision-maker identified during the intervention.  They speculated that this may have 
been the reason there was no statistically significant difference between those with and 
without the intervention. 
Satisfaction with care.  Along with having their preferences followed, patients 
and families who received an ACP intervention also report increased satisfaction with 
healthcare.  One study found that both discharged patients themselves and families of 
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deceased patients were significantly more likely to be highly satisfied with the hospital 
care they had received when ACP had been facilitated by use of an intervention (Detering 
et al., 2010).  Veterans Affairs medical centers also saw the same increase with patient 
satisfaction when advance care planning was undertaken (Engelhardt et al., 2006).  Other 
studies have focused on primary care and on specialty care and have also found that 
advance care planning increases patient satisfaction in those arenas as well (Kass-
Bartelmes & Hughes, 2009; Tierney et al., 2001).  The same increase in patient 
satisfaction has been seen in a variety of patient diagnoses, including cancer (Jones et al., 
2011), dementia (Sampson, 2011), and HIV (Lyon et al., 2009). 
Other studies have shown no significant difference in family/surrogate 
satisfaction with patient care.  Volicer, Hurley, and Blasi (2003) examined patients with 
dementia and compared those with and without advance care planning.  No statistically 
significant difference was found between the two populations of patients as to satisfaction 
with care.  Similarly, Pautex, Herrmann, and Zulian (2008) examined patients in 
palliative care for differences associated with the presence of advance directives.  No 
statistically significant differences were found between the two groups of patients as to 
satisfaction with the care they received.  This finding has also been seen in patients with 
HIV; one study showed a decrease in patient satisfaction after an ACP intervention, but 
this decrease was not statistically significant (Ho, Thiel, Rubin, & Singer, 2000). 
Improvements in end-of-life care.  Improved end-of-life care is another benefit 
of advance care planning.  Multiple studies have shown an improvement in this area, 
including decreases in unwanted hospitalizations, decreases in the use of mechanical 
ventilation or tube feeding, and increases in numbers of deaths at home or in a residence 
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other than a hospital.  Gozalo and colleagues (2011) examined the benefits of advance 
care planning documentation (including advance directives) in nursing home residents 
and found that those with such documentation were less likely to be hospitalized in the 
three months prior to death than those without it.  Similar results were shown by 
researchers studying the unit of admission; patients who had engaged in ACP were less 
likely to be admitted to a medical intensive care unit for aggressive treatment (Cohen et 
al., 2012).    
ACP has also been shown to decrease the rates of hospitalization for people living 
in extended care facilities.  Gozalo and colleagues (2011) looked at nursing home 
residents with advanced cognitive and functional impairment and found that those with 
advance directives had lower rates of hospitalization at the end of life.  Similarly, Molloy 
(2000), Morrison (2005), Caplan (2006), and Levy (2008) found that the use of an 
advance care planning intervention or improved documentation of advance care planning 
decreased later hospitalizations among nursing home residents.   
A related aspect is length of hospital stay; some studies have shown that ACP 
decreases both the length of the hospital stay in general, and length of ICU admission 
specifically, near the end of life.  Critically ill cancer patients had shorter ICU stays if 
they had ACP documented in their records (Wallace et al., 2001).  Volicer (2003) found 
similar results, with shorter hospital stays and increased numbers of deaths in nursing 
homes as opposed to in hospitals for patients with dementia who had completed ACP 
prior to death.  At least one other study, however, found no difference in the length of 
hospital stay between those with and those without advance care planning (Levy et al., 
2008). 
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Some research has shown that advance directives alone can impact the quality of 
a person’s end of life (Glavan et al., 2008), but results from several studies show no 
statistically significant relationship solely between the presence of advance directives and 
quality of life (Loberiza et al., 2011; Pautex et al., 2008; Vandervoort, 2014; Volicer et 
al., 2003).  However, more comprehensive ACP that includes discussions of preferences 
for care with both family and providers has been shown to produce improved quality of 
life, including both physical and psychological factors (Bischoff, Sudore, Miao, 
Boscardin, & Smith, 2013; Chan & Pang, 2010; Fried et al., 2009; Schamp & Tenkku, 
2006; Wright, Zhang, & Ray, 2008).  Conflicting research, however, has shown no 
correlation between improved quality of life and advance care planning in patients with 
cancer (Jones et al., 2011; Lyon et al., 2014).   
Benefits to surrogates.  ACP has also been shown to benefit people other than 
the patient.  Surrogates and family members often struggle with making healthcare 
decisions about patients, leading to psychological distress and even post-traumatic stress 
disorder (Kross et al., 2011).  This decisional conflict can lead to lead to making 
treatment decisions that are not aligned with the patient’s preferences (Barnato et al., 
2007; Cosgriff et al., 2007; Danis et al., 1996).  It can then lead to regret on the part of 
the surrogate and lower quality of life on the part of the patient (Cai et al., 2015; Tejwani 
et al., 2013).  Advance care planning, when it includes discussions with surrogates about 
goals of care, decreases surrogate and family stress, including allowing them to have 
more confidence in their decisions (Chiarchiaro, Buddadhumaruk, Arnold, & White, 
2015; Detering et al., 2010).  
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Financial effects.  Financially, ACP has been shown to decrease the use of 
aggressive medical treatment at the end of life, including admission to intensive care 
units (Ache et al., 2014; Bischoff et al., 2013; Wright et al., 2008; You, Fowler, & 
Heyland, 2014).  It is also correlated with increased use of hospice care, resulting in more 
deaths in hospice than in hospitals, because of ADs that specify comfort care at end of 
life instead of aggressive treatments (Wright et al., 2008). 
Barriers to Advance Care Planning 
Data from multiple studies show barriers to advance care planning on the parts of 
both the healthcare provider and the patient.  Commonly reported patient barriers on the 
include reluctance to ask questions, a fear of upsetting family members, a desire to leave 
any decision-making up to family, a perception that advance care planning does not apply 
to them, and misunderstanding the purpose of ACP.  Commonly reported provider 
barriers include not wanting patients to lose hope, not being experienced enough to 
discuss ACP, and waiting until patients ask to discuss ACP. These barriers will be 
discussed in more detail in the next section. 
Patient barriers.  Patients’ reluctance to ask questions about their disease 
processes is a primary barrier to engaging in ACP (Caldwell, Arthur, & Demers, 2007; 
Harding et al., 2008; Strachan et al., 2009).  This reluctance can stem from a fear that 
they will place the provider in an uncomfortable position in having to discuss EOL care 
or that the provider will not be ready to have such a discussion (Caldwell, Arthur, & 
Demers, 2007).  Some patients also fear that they would be labeled as “difficult” patients 
if they question their providers about prognosis and advance planning (Boyd et al., 2004).  
Patients also report concerns that the provider will not give them truthful information and 
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thus refrain from initiating the conversation (Harding et al., 2008; Strachan et al., 2009).  
Many patients also believe that physicians do not have the time to talk to them about 
prognosis and advance planning (Aldred, Gott, & Gariballa, 2005).  
Patients also report that they believe the provider should initiate advance care 
planning, which is thus a barrier to patient initiation of ACP (Caldwell, Arthur, & 
Demers, 2007; Rodriguez et al., 2008b).  Many patients think that the provider will 
initiate such discussions when it is appropriate, i.e., that the disease is terminal (Caldwell, 
Arthur, & Demers, 2007; Rodriguez et al., 2008a).  Lack of initiation on the part of the 
provider has led patients to believe that ACP is not yet needed (McCormick, 2009).   
Patients may not initiate discussions about prognosis and advance care planning 
because of anxiety or a desire to focus only on the positive (Agard, Hermeren, & Herlitz, 
2004; Barnes et al., 2006; Boyd, Murray, Kendall, Worth, Benton, & Clausen, 2004; 
Horne & Payne, 2004).  This may be a coping strategy for some patients (Heffner, 2011).  
Many patients report not asking for prognostic information because they did not want to 
lose hope, but also because they feel it is unnecessary as they cannot change it (Agard, 
Hermeren, & Herlitz, 2004).  Other patients may be in a state of denial about the 
seriousness of their disease, and thus either do not initiate ACP or refuse to discuss it if 
initiated by the provider (Gardiner et al., 2009). 
Crain (1996) studied frail homebound elderly and found that one of the most 
common reasons for failure to complete advance directives was that study participants 
were afraid that it would upset their family members.  Schickedanz et al. (2009) studied 
143 people over age 50 from a general medicine clinic and found that 43% of them did 
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not participate in advance care planning because of not wanting to worry or burden their 
families.   
Finally, there are some cultural barriers to engaging in ACP.  Some people fail to 
engage in ACP because of a desire to leave decision-making up to their families.  Studies 
of decision-making of African-Americans have shown that many prefer to allow their 
family members to make future healthcare decisions for them (Daaleman, Emmett, 
Dobbs, & Williams, 2008).  Phipps (2003) hypothesized that this may be because they 
feel that family members already know their wishes, and thus there is no need for 
advance directives.  Other studies have revealed data similar to this, with Wagner (2003) 
noted that living wills were less likely to be completed by African-Americans than 
Caucasians, and Guo (2010) noting that those of Hispanic or Latino origin were less 
likely to have both advance directives and DNR orders when afflicted with end-stage 
cancer.   
Cultural differences between different ethnicities may also be related to religion.  
In African-Americans, religious values, rather than healthcare provider 
recommendations, are often the guiding force for decision-making for ACP (Johnson, 
Elbert-Avila, & Tulsky, 2005).  End-of-life choices are also affected by religiosity and 
culture, as religious beliefs tended to be different between different ethnicities in one 
study (Bullock, 2011).  Religion and ethnicity as factors affecting engagement in ACP 
are also discussed later in this chapter. 
Provider barriers.  Providers also encounter barriers to initiating ACP 
conversations, most notably reporting a lack of confidence in their communication skills 
(Harding et al., 2008; Selman et al., 2007).  In one qualitative study, cardiologists’ EOL 
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communication skills were compared to those of oncologists, and cardiologists’ skills 
were found to be lacking (Selman, 2007).  Patients recognize this deficiency in 
communication skills, noting that EOL communication from providers was “poor” or 
nonexistent (Horne & Payne, 2004; Rodriguez et al., 2008a).  Other patients find that 
provider communication is poor not only when related to advance planning and 
prognosis, but also about daily care activities (Boyd et al., 2004; Gerlich, Klindtworth, 
Oster, Pfisterer, Hager, & Schneider, 2012).   
Physicians report that they do not want to remove all hope and do not want to 
cause any psychological or emotional distress in their patients by initiating EOL 
conversations (Harding et al., 2008).  Because of this, they then use less severe words 
than “terminal” or “fatal,” resulting in patient misconceptions about prognosis 
(Ahluwalia et al., 2013).  
Advance Care Planning in Heart Failure 
It is difficult for physicians to accurately identify when patients with heart failure 
are approaching end of life because heart failure has an unpredictable trajectory, with 
frequent relapses and improvements (Garland, Bruce, & Stajduhar, 2013).  Advance care 
planning conversations therefore cannot be delayed until death is imminent.  
Additionally, because of the wide variety of treatment options available, including both 
non-invasive treatments such as oral medications and invasive therapies such as 
pacemakers, continuous intravenous medications, and even ventricular assistive devices, 
the decisions to be made become increasingly complex as the disease progresses 
(Garland, Bruce, & Stajduhar, 2013).   
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Despite the national focus on advance care planning and the desires of the 
patients, many studies of patients with heart failure show that the majority of them report 
no experience participating in any type of advance care planning, including end-of-life 
planning, with their healthcare providers (Barclay et al., 2011; Gott et al., 2008; Momen 
& Barclay, 2011; Rodriguez et al., 2008; Strachan et al., 2009).  Many of those who did 
discuss end-of-life care reported only discussions about resuscitation and completion of 
legal paperwork rather than in-depth examinations about goals for future care (Barclay et 
al., 2011).  The timing of such conversations is often at the very end of life, when the 
family is called upon to make decisions, or during times of clinical crisis, when the 
patient is unable to focus on anything but physical symptoms (Ahluwahlia et al., 2013).  
This lack of ACP often results in the neglect of consideration of patient values 
concerning treatment and contributes to stress to SDMs as previously discussed. 
Conceptual Model 
Trans-Theoretical Model 
The Trans-Theoretical Model (TTM) was first proposed as a way to understand 
both the stages of behavior change and the processes related to change when individuals 
were trying to overcome addictive behaviors such as smoking (Prochaska, DiClemente & 
Norcross, 1992).  The TTM involves multiple actions and adaptations that occur over 
time.  The stages of changes describe a person’s readiness to act on a new behavior; a 
person may cycle through the stages in a “spiral” or revert back to an earlier stage at any 
time (Prochaska, DiClemente & Norcross, 1992).  The five stages of change are: (1) 
precontemplation; (2) contemplation; (3) preparation; (4) action; and (5) maintenance 
(Prochaska & Velicer, 1997).  Precontemplation is the stage in which a person has no 
37 
intention of changing behavior and may even be unaware of the need for a change.  In 
contemplation, a person is aware that there is a need to change, but has no commitment to 
take action.  Preparation involves a person’s intention to take action in the near future.  
Action is the stage in which a person actually modifies behaviors, experiences and/or 
environments.  Finally, maintenance involves stabilization of the new behavior over a 
period of time.  A sixth stage, termination, is sometimes added; this stage indicates that 
there is no risk of returning to the old behavior.  These stages are not necessarily always 
linear; many individuals will regress and progress through the stages based on motivation 
and self-efficacy or lack thereof (Whitelaw et al., 2000).  Interventions based on the TTM 
have been shown to be effective in a variety of health behaviors including smoking 
cessation, regular mammography screening, medication adherence, and improving 
dietary habits (Johnson et al., 2006; Jones et al., 2003; Krebs, Prochaska, & Rossi, 2010; 
Prochaska et al., 2005).  Interventions based on the TTM have been successful largely 
because they are specifically designed to target individuals at certain stages of change 
(Fried et al., 2016).   
Model of Engagement in Advance Care Planning 
The current research is based upon the TTM and adds in certain patient 
characteristics and experiences that could affect a person’s stage of change as related to 
ACP.  These characteristics are considered potential predictor variables in the model and 
include health variables such as ACCF/AHA heart failure stage, comorbidities, and 
perception of health status, personal experiences such as recent hospitalizations and 
making healthcare decisions for others, and sociodemographic characteristics such as age, 
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gender, ethnicity, marital status, income, education level, and health literacy.  Figure 4 
illustrates the model for the currently proposed research (Chapter 1, page 10).  
Health Variables 
ACCF/AHA heart failure stage and NYHA heart failure classification.  The 
stages, as previously described, are based upon the progressive nature of heart failure and 
are a continuum from asymptomatic but at-risk individuals to those with severe physical 
limitations due to the disease (Oh & Borlaug, 2015).  People with heart failure progress 
through the stages via periodic exacerbations and stable periods, but each exacerbation 
may lead to death.  The mortality rate increases as a person progresses through the stages, 
as do the chances the person will need urgent medical treatment and intensive care (Allen 
et al., 2012).  In the Model, heart failure stage is hypothesized to be a predictor variable 
because of its impact not only on patient symptoms, but also on a patient’s risk of death 
within a short period of time.  Classes are also on a continuum and, similarly, impact both 
patient symptoms and risk of death.  The association between stage and class was 
illustrated in Table 2. 
 Comorbidities.  Comorbidities are hypothesized to be a factor that helps to 
predict engagement in advance care planning.  Comorbid conditions are those with which 
a patient has been diagnosed in addition to heart failure.  Common conditions include 
diabetes, coronary artery disease, renal disease, and chronic obstructive pulmonary 
disease (COPD).  As a patient’s number of comorbid conditions increases, the deleterious 
symptoms increase, as does the risk of mortality (Ahluwalia et al., 2012).  Comorbidity 
has been found to be a factor that affected engagement in ACP in previous studies.  Bond 
et al. (2018) examined medical records in a large-scale study (over 120,000 patients over 
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a four-year period) involving a multisite rural-suburban facility and found that the 
patients with documented ACP had higher numbers of comorbid conditions.  Having 
heart failure or chronic obstructive pulmonary disease (COPD) also increased the 
likelihood of having ACP documentation in their medical records.  Hash, Bodnar-Deren, 
Leventhal, and Leventhal (2016) found that the odds of participating in ACP increased 
with the presence of comorbid chronic illnesses such as heart disease, diabetes, and 
cancer.   
Patient perception of health status.  Patient perception of health status is 
hypothesized to be a variable that helps to predict engagement in advance care planning.  
Early testing of the ACPES across healthcare settings showed that patients with higher 
perceived health status were less likely to be engaged in advance care planning than those 
with chronic health conditions such as renal failure and cancer (Howard et al., 2016).  
Additionally, preparatory work by this researcher for the current study demonstrated that 
patients felt their answers to the ACPES could change given their view of their health 
that day and the way they currently felt (Catalano, 2016). 
Patient Experiences 
Recent hospitalizations.  Recent hospitalizations (within the previous two years) 
are hypothesized to affect engagement in ACP.  Experience with recent hospitalizations 
is important because patients are asked about the presence of any advance directives 
when admitted to a facility, potentially triggering patient activity regarding advance care 
planning.  Howard et al. (2016) found that patients who were currently hospitalized were 
more likely to have completed certain ACP actions, including selection of a healthcare 
proxy and discussion of healthcare preferences with providers.   
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 Making healthcare decisions for others.  Making healthcare decisions for others 
is hypothesized to affect engagement in ACP.  Making healthcare decisions for others, as 
happens when one is a surrogate decision maker, could potentially trigger patient activity 
regarding advance care planning.  This variable was included in the model because 
knowledge about a health behavior can move a person from precontemplation to 
contemplation (Zimmerman, Olsen, & Bosworth, 2000).  The effect of the experience of 
serving as a surrogate on one’s own ACP has not been well-studied in the literature.  
Recently, Genewick and colleagues (2018) researched motivating factors for creating 
ADs, and included a question regarding making end-of-life decisions for others on their 
survey.  Their research focused on whether intrinsic (dignity and personal control) or 
extrinsic factors (societal and familial influence) were more motivating, and did not 
separate out the individual variables.  However, they did find that extrinsic factors were 
more motivating for patients older than age 50.  Another study examining motivating 
factors showed that 31% of people who completed advance directives did so after seeing 
a family member or friend die from a serious illness (van Wijmen, Pasman, 
Widdershoven, & Onwuteaka-Philipsen, 2014).  The study did not examine whether they 
had themselves made healthcare decisions for the dying person. 
Sociodemographic Variables 
Age.  Age is a factor that has been shown to affect stage of readiness to engage in 
advance care planning (Fried et al., 2010).  Although age was not a factor that influenced 
readiness to complete an advance directive in one study, it did impact whether or not a 
person was ready to discuss quality of life with loved ones, surrogate decision makers, 
and providers (Fried et al., 2010).  Those between 65 and 74 years of age were more 
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likely to be in the action phase of communicating with loved ones about quality of life 
(Fried et al., 2010).  Nursing home residents aged 75 years and older have also been 
found to be more likely to have advance care plan documentation, including “do not 
resuscitate” orders, on file (Dobalian, 2006).  Older patients are also more likely to have 
dementia symptoms; however, the presence of dementia may decrease the likelihood of 
having end-of-life provisions documented (Mitchell, Kiely, & Hamel, 2004).  Age 
continues to be a variable that impacts ACP in recent research.  In 2016, Inoue reviewed 
over 1000 participants’ information about ACP and found multiple sociodemographic 
variables that increased the likelihood of having been engaged in ACP, including age.  
Inoue found that the older a person was, the more motivated he or she was to engage in 
ACP.  Studies have also examined the effect of age in different ethnic groups; Boucher 
(2017) found that young age was a barrier to ACP in people in New York with Puerto 
Rican and Dominican ancestry. 
Gender.  Gender is a factor that has been shown to affect stage of readiness to 
engage in advance care planning (Fried et al., 2010).  Although gender was not a factor 
that influenced readiness to complete an advance directive in one study, it did impact 
whether or not a person was ready to discuss quality of life with loved ones, surrogate 
decision makers, and providers (Fried et al., 2010).  Men were more likely to be in the 
action phase than women for communicating with loved ones about quality of life.  A 
recent study found that men are less likely to have engaged in ACP than women (Doyle, 
2016).  Inoue (2016) found that women were more likely to have been motivated to 
engage in ACP than men in a review of over 1000 participants.  Similarly, Boerner, Carr, 
and Moorman (2016) found that women were more likely to have engaged in ACP than 
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men in a study of almost 300 adults aged 55 years and older who were diagnosed with 
diabetes, cancer, or heart failure.   
Ethnicity.  Ethnicity is a factor that has been shown to affect the completion of 
living wills (Fried et al., 2010).  Being nonwhite is associated with a lower stage of 
change than being white; 60% of white study participants were in the action/maintenance 
phase, indicating that the living will had been completed or was in process.  Only 26% of 
those participants who were nonwhite were in this stage; 41% were still in the 
precontemplation stage (Fried et al., 2010).  Being African-American has also been 
shown to impact engagement in ACP (Fried et al., 2010; Johnson, Kuchibhatla, & 
Tulsky, 2008); lower rates of engagement have been theorized to be due to mistrust of the 
healthcare system (Johnson, Kuchibhatla, & Tulsky, 2008).   
In one study, African-Americans were found to be only one-third as likely than 
Caucasians to have living wills, but Hispanics were just as likely to have them as 
Caucasians (Degenholtz, Arnold, Meisel, & Lave, 2002).  Disparities were also seen in 
the percentages of “do not resuscitate” orders, even after controlling for health status and 
other demographic factors such as age, gender, and marital status (Degenholtz, Arnold, 
Meisel, & Lave, 2002).  Later studies found similar results, with both black and Hispanic 
patients being less likely than white patients to have engaged in ACP (Dobalian, 2006; 
Smith et al., 2008).  These ethnic differences were still present after controlling for 
clinical and demographic factors (Smith et al., 2008).  A recent study found that African-
Americans and Latinos are less likely to have engaged in ACP (Doyle, 2016).  Elderly, 
Spanish-speaking Latinos were the least likely to have engaged in ACP (Doyle, 2016). 
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Marital status.  Marital status is a factor that has been shown to affect stage of 
readiness to engage in advance care planning (Fried et al., 2010).  Marital status impacted 
whether or not a person was ready to discuss quality of life with loved ones, surrogate 
decision makers, and providers, with married people more likely to be in the 
action/maintenance phase of this task, and unmarried people more likely to be in the 
precontemplation phase (Fried et al., 2010).  Married couples are also more likely to 
engage in ACP than those cohabiting, but this may also have been influenced by age, as 
older participants were more likely to be married than cohabiting (Moorman, Carr, & 
Boerner, 2014).  Higher levels of spousal support also increase the odds of having ACP 
discussions with a spouse (Boerner, Carr, & Moorman, 2013). 
Income.  Sufficiency of monthly income may impact engagement in advance care 
planning.  One study found that nursing home residents with Medicaid were less likely to 
have an advance care plan than those with Medicare or other forms of healthcare 
payments (Dobalian, 2006).  Residents with income less than 400% of the Federal 
Poverty Level were also less likely to have a living will (Dobalian, 2006).  A recent, as 
yet unpublished study found that people with low annual incomes are less likely to have 
engaged in ACP (Doyle, 2016).   
Education.  Education level has been implicated in engagement in advance care 
planning.  Bullock (2011) found that study participants with lower levels of education 
were less likely to have engaged in advance care planning; however, this may have been 
biased by other factors, including ethnicity and perceived health status.  Limited 
education among Latino patients was also shown to affect advance care planning and 
end-of-life preferences, but these differences were eliminated when educational materials 
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were provided in an appropriate format (video) and at an appropriate level (Volandes, 
Ariza, Abbo, & Paasche-Orlo, 2008).  Doyle (2016) found that people with lower levels 
of education are less likely to have engaged in ACP. 
Religion.  Religion has been shown to be a factor affecting advance care 
planning, with religiosity having a negative correlation with the likelihood of advance 
care planning (Garrido, Idler, Leventhal, & Carr, 2013).  This has been theorized to be 
due in some part to the influence of fundamentalist religions (Sharp, Carr, & Macdonald, 
2012).  End-of-life choices are also affected by religiosity and spirituality, but this may 
also be affected by ethnic differences, as religious beliefs tended to be different between 
different ethnicities in one study (Bullock, 2011).  One recent study indicated that 
patients who considered themselves atheists were more likely to have completed 
documents limiting treatment at the end of life than patients who were Catholic or 
Protestant (Janssen et al., 2016). 
Health literacy.  Health literacy has been found to be a factor influencing rates of 
advance care planning, with adults of low health literacy levels being less likely to 
complete advance directives (Sudore et al., 2007).  Changes to the educational materials, 
including showing videos of certain medical treatments, have been found to eliminate 
disparities in ACP based on health literacy (Vig, Berg, & Simon, 2012). 
Engagement in Advance Care Planning 
Recently, Fried and colleagues examined the TTM to determine if it was a valid 
model to predict engagement in advance care planning (2009).  They noted that 
behavioral change theories were especially appropriate for ACP theories because they 
included constructs such as perceived susceptibility, self-efficacy, and barriers to change, 
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and also a temporal component indicating that it was a process rather than a single event 
(Fried et al., 2009).  They conceptualized ACP as a series of health behaviors that require 
people to go through behavior change (Fried et al., 2009).  These behaviors included not 
only completion of a living will and healthcare proxy, but also communication with both 
loved ones and providers about the use of life-sustaining treatments and quantity versus 
quality of life (Fried et al., 2009).  The study participants included both community-
dwelling older adults and caregivers with experience as surrogate decision-makers.  The 
qualitative study revealed several themes, including a variable readiness to engage and 
multiple barriers, validating the researchers’ theories that it was a process through which 
people progressed at different rates (Fried et al., 2009).  They concluded that 
interventions to increase rates of ACP should be customized “based on an individualized 
assessment of a person’s readiness to change, barriers to and facilitators of change, and [a 
person’s] use of processes of change” (Fried et al., 2009, p. 1552). 
Fried et al. (2010) later conducted an observational study to develop measures to 
determine stage of change for the component behaviors of the ACP process, and to use 
these measures to examine sociodemographic and health variables that could impact 
stages of change.  The study participants were recruited from physician offices and 
community centers and averaged 75 years of age, and were of diverse ethnic origin, 
marital status, and quality of life (Fried et al., 2010).  The results of the study confirmed 
that the stages varied for each discrete ACP behavior; individuals could be in the action 
phase for completion of advance directives, but still be in the contemplation phase for 
discussion with providers and loved ones (Fried et al., 2010).  Data showed that the 
participants were in the lowest stage of change for communication with physicians about 
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quality of life, with only 7% in either the preparation or action stage (Fried et al., 2010).  
Communication with physicians about life-sustaining treatment was also in a low stage of 
change; only 14% of people were in either the preparation or action stage (Fried et al., 
2010).   
In further work based upon these original studies, Sudore pulled concepts from 
social cognitive and behavioral change theories and noted that behavior change requires 
an individual to change several factors related to any particular behavior.  These factors 
include: (1) knowledge of the importance of the behavior; (2) contemplation about the 
behavior; (3) self-efficacy to perform the behavior; and (4) readiness to perform the 
behavior (Sudore et al., 2013).  Knowledge of the importance of the behavior is 
dependent upon an awareness that a risk exists (Conner & Norman, 2005).  Changing 
risky behaviors such as smoking, for example, require knowledge that smoking is 
harmful to one’s health.  Contemplation refers to the phase in which one is thinking about 
changing a certain behavior, but has not yet taken any steps toward this change (Conner 
& Norman, 2005; Prochaska & Velicer, 1997).  Knowledge of the health threat is a 
prerequisite to this stage (Conner & Norman, 2005).  Self-efficacy refers to believing in 
one’s capability to successfully complete a certain behavior change (Bandura, 1977; 
Conner & Norman, 2005).  Lack of self-efficacy will typically stall a person in either the 
contemplation or preparation stage of the TTM (Sutton, 2005).  Finally, the concept of 
readiness indicates that a person is ready to change with regard to a particular behavior 
(Abraham & Sheeran, 2005).  Readiness has a temporal factor in that it is not a 
willingness to change later, but at the present time (Abraham & Sheeran, 2005). 
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Advance Care Planning Engagement Survey.  Based on the previous factors 
related to behavior change and the TTM stages of change, Sudore and colleagues 
developed the Advance Care Planning Engagement Survey (ACPES) in order to measure 
a person’s engagement in each discrete behavior within the ACP process (Sudore et al., 
2013).  The ACPES examines four domains of ACP: decision makers, quality of life, 
flexibility, and asking questions.  The “decision makers” domain includes identification 
of a surrogate decision maker and informing them and the providers of the responsibility.  
“Quality of life” refers to the identification of the person’s values and goals and 
communicating them to the surrogate and provider.  The “flexibility” domain includes 
communicating the amount of leeway the surrogate will have in making decisions.  
Finally, the “asking questions” domain refers to preparedness to ask providers questions 
in order to make informed care decisions.  Each of the four domains includes several 
specific behaviors based on the TTM: knowledge, contemplation, self-efficacy, and 
readiness.   
The ACPES originally measured both cognitive processes and actions related to 
each domain, but has since been adapted for brevity.  The 31 process measures are related 
to knowledge, contemplation, self-efficacy, and readiness.  For knowledge, the ACPES 
asks the patients how well-informed they are about the domains of decision makers, 
flexibility, and asking questions (quality of life was omitted from this behavioral 
process).  For contemplation, the ACPES asks the patients how much they have thought 
about each of the four domains.  Self-efficacy is assessed by asking patients how 
confident they are that they could perform the ACP behaviors.  Finally, readiness is 
assessed by asking patients how ready they are to perform those same behaviors.  Each of 
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these is measured on a 5-point Likert-type scale.  The 18 action measures of the ACPES 
were specific yes/no questions to determine if a person was in the action stage of change 
related to each of the four ACP domains (Sudore et al., 2013), but have since been 
eliminated in the new version of the ACPES (Sudore et al., 2017a).  Figure 5 illustrates 
the interaction of the behavioral change processes and actions with the ACP domains 
(used with permission from Sudore et al., 2013). 
Figure 5: Interaction of ACP Domains, Behavioral Processes, and Actions  
 
In a diverse sample of 50 older adults from outpatient clinics, nursing homes, and 
community clinics and 20 younger healthy adults, Sudore (2013) found that the mean 
overall process measure score was 3.7 on a 5-point Likert scale ranging from not at all to 
extremely likely.  The 20 younger healthy adults in the study had an overall process 
measure mean of 2.7, with the older adults having an overall process measure mean of 
4.4.  In the older adults, the mean total score for action measures (total possible score of 
18) was 10.1, and the mean total score for action measures in the younger adults was 5.3.  
Comparisons between the demographic characteristics of the older and younger adults 
were also provided, although there were no data about possible correlations between 
these and the engagement scores.  More of the older adults were extremely religious, and 
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just under one-half of them were married; these factors may have impacted the 
differences in scores.  Prior advance care planning experience, including making 
decisions for others, was much more common in the older adults.  
The ACPES has been tested for reliability and validity.  One-week test-retest 
intraclass correlation (ICC) was used to estimate the survey’s reliability and indicates the 
survey measures the outcome the same way, in a stable study participant, each time it is 
used (Tabachnick & Fidell, 2012).  ICC values over 0.8 indicate almost perfect 
agreement; ICC values of 0.7 to 0.8 indicate strong agreement; and ICC values of 0.5 to 
0.6 indicate moderate agreement.  The ICC for the ACPES was 0.70 for process measures 
overall (Sudore et al., 2013).  For each subscale of knowledge, contemplation, self-
efficacy, and readiness, the one-week test-retest ICCs were 0.70, 0.56, 0.60, and 0.69, 
respectively (Sudore et al., 2013).  Cronbach’s alpha was also calculated to estimate 
internal consistency; this test should have a value above 0.7 (Tabachnick & Fidell, 2012).  
Cronbach’s alpha was calculated as 0.94 for the process measures overall (Sudore et al, 
2013).  It was calculated as 0.84, 0.86, 0.83, and 0.92 for each subscale of knowledge, 
contemplation, self-efficacy, and readiness, respectively (Sudore et al., 2013).  For the 
action measures, the overall ICC was 0.87 and was 0.81, 0.87, 0.83, and 0.57 for the 
subscales of decision makers, quality of life, flexibility, and asking questions, 
respectively (Sudore et al., 2013). 
The ACPES was recently modified and tested for feasibility in a convenience 
sample of 196 patients from primary care practices, hospitals, cancer care centers, and 
dialysis centers (Howard et al., 2016).  The modifications included 33 additional 
unvalidated questions; 18 questions were added to the quality of life domain and 12 
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questions were added to the decision makers domain.  The three remaining additional 
questions related to readiness to decide on a healthcare decision maker.  The time to 
complete the modified survey averaged from 34 minutes to one hour, leading the 
researchers to conclude that it may not be feasible to administer the lengthy survey in a 
hospital setting (Howard et al., 2016).  However, questions about acceptability of the 
survey yielded means from good to very good from the study participants and indicated 
that the participants did not find the survey burdensome to complete (Howard et al., 
2016). 
The ACPES has been further modified to become shorter and more feasible, and 
then tested to reflect validity of shorter versions (Sudore et al., 2017a).  Sudore (2017a) 
tested the ACPES as 82, 55, 34, 15, nine, and four items with a sample of 664 patients of 
varying demographic characteristics.  The 55-, 34-, and 15-item modifications were 
found to have internal consistency and construct validity similar to the 82-item survey.  
The smallest surveys, of nine and four items, were recommended for use in quality 
improvement settings or in clinical studies with limited resources. 
Summary 
 ACP has been shown to improve quality of life and satisfaction with care, both at 
end of life and while people are coping with terminal illnesses.  ACP has evolved from 
the completion of legal documents such as living wills and appointment of SDMs to an 
ongoing process that involves multiple behaviors.  A person’s involvement in ACP may 
be impacted by a variety of demographic factors, including age, marital status, education, 
and religiosity.  Health factors, such as presence and severity of illnesses, may also 
impact a person’s involvement.  Engagement in ACP can be measured through the use of 
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Sudore’s (2013) ACPES, which assesses factors such as discussion of values and 
preferences for care with family and healthcare providers, appointment of SDMs, and 
creation of living wills.  Increasing knowledge of how the demographic and health factors 
impact engagement in ACP will help in the development of interventions that increase 
involvement in ACP, which then in turn will improve quality of life and satisfaction with 
care. 
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CHAPTER 3 
METHODS 
This chapter will provide a description of the methods used to assess the 
relationship between heart failure and advance care planning in the study.   
Design 
 A descriptive correlational study design was used to measure the frequency of 
advance care planning among a sample of patients with heart failure and to examine the 
relationship between their engagement in advance care planning and their ACCF/AHA 
heart failure stage, comorbid conditions, perception of health status, and recent 
hospitalizations.  Data was collected from participants using a self-report survey 
distributed by mail. 
Research Aims 
 The specific aims and research questions of the study were: 
Specific Aim 1: To describe advance care planning engagement in patients with heart 
failure. 
Research questions for Specific Aim 1 include: 
1A.  What are the characteristics of patients who are participating in this 
study of advance care planning? 
1B.  What percentage of patients in this study report having appointed a 
surrogate decision-maker for health care decisions? 
1C.  What percentage of patients in this study report discussions of values 
and goals of care with surrogate decision-makers? 
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1D.  What percentage of patients in this study report discussions of values 
and goals of care with healthcare providers? 
1E.  What percentage of patients in this study report having completed 
advance directives? 
Specific Aim 2: To explore the association between patient engagement in advance care 
planning and ACCF/AHA heart failure stage; NYHA heart failure class; comorbidity 
index; patient perception of health status; recent hospitalizations; and the 
sociodemographic variables of age, gender, ethnicity, marital status, income, education, 
and religiosity. 
Research questions for Specific Aim 2 include: 
2A. What is the strength of the association between engagement in advance 
care planning and ACCF/AHA heart failure stage? 
2B. What is the strength of the association between engagement in advance 
care planning and NYHA heart failure class? 
2C. What is the strength of the association between engagement in advance 
care planning and patient comorbidities? 
2D. What is the strength of the association between engagement in advance 
care planning and patient perception of health status? 
2E. What is the strength of the association between engagement in advance 
care planning and any recent hospitalizations? 
2F. What is the strength of the association between engagement in advance 
care planning and making healthcare decisions for others? 
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2G. What is the strength of the association between engagement in advance 
care planning and the sociodemographic variables of age, gender, ethnicity, 
marital status, income, education, religion, and health literacy? 
Setting 
 Study participants were recruited from the offices of The Ohio Heart and Vascular 
Center (OHVC), a division of The Christ Hospital Physicians, in Cincinnati, Ohio.  The 
Christ Hospital is a 529-bed, not-for-profit, acute care teaching hospital in an urban area 
of Cincinnati, Ohio.  It is rated as “high performing” in heart failure by U.S. News and 
World Report, indicating that the patient outcomes are significantly better than the 
national average (U.S. News, 2016).  The Christ Hospital Physicians is the physician 
organization of The Christ Hospital Health Network.  OHVC patients are primarily 
residents of Cincinnati, Ohio, and its surrounding suburbs.  Each of the four heart failure 
physicians in the group sees approximately 800 to 1100 patients annually with differing 
stages of heart failure. 
Sampling 
 The study population included patients with varying stages of heart failure.  The 
study sample was drawn from those patients seen at the Ohio Heart and Vascular Center 
(OHVC) by cardiologists specializing in heart failure.  This office uses the electronic 
medical software Epic, which contains demographic and diagnostic information including 
physical assessment data, diagnostic test reports, physician notes, and patient plans of 
care.  The office staff ran a query on the electronic medical record database to obtain 
names of all patients seen for heart failure in the previous 13 months.  Patients are seen, 
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at minimum, on an annual basis, so this time frame was chosen to capture all active 
patients.   
After OHVC staff identified the potential participant pool, a list of their names 
was provided to the investigator.  The investigator received access to Epic through 
OHVC after The Christ Hospital’s IRB approved the current study.  For recruitment 
purposes only, the investigator reviewed the electronic medical records of the identified 
OHVC heart failure patients to determine whether the patients met the inclusion criteria.  
The criteria for inclusion in the present study were: 
1. diagnosis of heart failure;  
2. under the care of The Ohio Heart and Vascular Physicians within the previous 13 
months; and 
3. age 18 or older. 
Exclusion criteria included: 
1. diagnosis of congenital heart disease;  
2. diagnosis of dementia; or 
3. required translator as noted in Epic. 
Patients with congenital heart disease such as hypoplastic left heart syndrome, congenital 
valvular disorders, or septal defects were excluded because the trajectory of this type of 
heart disease is markedly different from those who are diagnosed with heart failure in 
adulthood.  Those with a documented diagnosis of dementia were excluded to help ensure 
that study participants had the capacity both to consent to participate and to engage in 
advance care planning. 
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The researcher identified the ACCF/AHA heart failure stage (A, B, C, or D – see 
description in Chapter 2) and NYHA heart failure class (1, 2, 3, or 4 – see description in 
Chapter 2) of each potential participant by querying the electronic medical record, as this 
information is routinely documented by the OHVC providers.  The researcher then 
employed disproportionate stratified sampling.  Stratified sampling refers to the division 
of the population into separate groups, called strata.  With disproportionate stratified 
sampling, the sample size of each stratum does not have to be proportionate to the 
population size of the stratum.  The intent was to achieve approximately equal numbers 
of participants of each ACCF/AHA stage of heart failure (stages A through D).  
However, because there were fewer patients in stage D, there were not enough potential 
participants in Stage D to construct groups of the same size.  In order to increase the total 
number of surveys mailed, additional participants from Stage C received surveys, 
because this was the next closest stage in severity.  The initial mailing included 125 
participants in Stage A, 125 in Stage B, 192 in Stage C, and 58 in Stage D.  A second 
mailing was sent to 363 nonresponders from the initial sample along with 140 new 
participants.  A third mailing was added and the survey was sent to 67 new participants. 
Sample Size 
Sample size is an important consideration in study planning and necessary for the 
reduction of Type II errors.  Necessary sample size was calculated based on a power 
analysis with a desired power of 0.8.  Power analysis for a regression analysis with 39 
predictors was conducted online using the program G*Power to determine a sufficient 
sample size using an alpha of 0.05, a power of 0.80, and a medium effect size (f2 = 0.15) 
(Faul, Erdfelder, Lang, & Buchner, 2007).  Based on the aforementioned assumptions, 
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the desired sample size was 211.  With 39 predictors, however, the ideal sample size was 
390, and thus the overall goal was to receive completed surveys from approximately100 
participants from each stage of heart failure.  
Human Subjects Protection 
The study protocol was approved by the Institutional Review Boards at Indiana 
University–Purdue University (IUPUI) in Indianapolis, Indiana and The Christ Hospital 
in Cincinnati, Ohio.  The survey was deemed expedited under category 7 because it 
“involve[d] no more than minimal risk” to the study participants (45 C.F.R. § 
46.110(b)(1)).  
The IU IRB also served as the HIPAA review board.  An initial waiver of HIPAA 
authorization for recruitment was requested from the IRB.  The waiver allowed the 
investigator to review electronic medical records to identify potential study participants.  
Once identified, each potential participant was assigned a randomly generated number.  A 
key containing the numbers and names of potential participants was stored in a password-
protected, secure database accessible only by the principal investigators.  Names were 
retained for the sole purpose of personalizing the introductory letter sent to potential 
participants.   
Potential participants received an introductory letter and information sheet that 
contained the elements of informed consent but did not require a signature.  The 
information sheet included an explanation of the research, a contact number for the 
investigator, and a contact number for the Indiana University IRB in case of questions 
about their rights as a research participant.  It also included a statement about the risk of 
the research, which was a potential loss of confidentiality.  Consent was implied when 
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participants completed and returned the survey to the investigator.  All participants who 
returned the survey within two weeks and provided their contact information were 
entered into a drawing for three $50 gift cards to a local grocer of their choice; those who 
returned the materials after the reminder were entered into a drawing for three $25 gift 
cards to a local grocer of their choice.  The investigator examined medical records of 
those participants who returned the survey in order to ascertain comorbid conditions, one 
of the predictor variables in the model.  
Measures 
Engagement in Advance Care Planning 
The primary dependent variable in this study was engagement in advance care 
planning.  This variable was measured by the Advance Care Planning Engagement 
Survey (ACPES), developed and modified by Sudore and colleagues (2017).  The 
ACPES is based on Prochaska’s Trans-Theoretical Model (TTM), which was developed 
to understand the stages of change and the processes related to change (Prochaska, 
DiClemente, & Norcross, 1992).  The TTM includes multiple actions and adaptations that 
occur over time.  As described in Chapter 2, the stages of changes assess a person’s 
readiness to act on a new behavior; a person may cycle through the stages in a “spiral” or 
revert back to an earlier stage at any time (Prochaska, DiClemente & Norcross, 1992).  
The five stages of change are: (1) precontemplation; (2) contemplation; (3) preparation; 
(4) action; and (5) maintenance (Prochaska & Velicer, 1997).  The ACPES also 
incorporates Social Cognitive Theory and Behavior Change Theory, which indicate that 
any change in behavior requires an individual to change several factors related to any 
particular behavior, including: (1) knowledge of the importance of the behavior; (2) 
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contemplation about the behavior; (3) self-efficacy to perform the behavior; and (4) 
readiness to perform the behavior (Sudore et al., 2013).   
The ACPES includes four domains: decision makers, quality of life, flexibility, 
and asking questions.  The ACPES measures cognitive processes related to each domain 
using 5-point Likert-style questions.  The questions are based on how much an individual 
has thought about ACP-related topics, including personal values and goals of healthcare 
and the appointment of a surrogate decision maker.  The 5-point scale asks respondent to 
rate their answers from one, meaning “not at all,” to five, meaning “extremely.”  
The questions in the ACPES are categorized according to the sub-scales of 
knowledge, contemplation, self-efficacy, and readiness described above.  The knowledge 
subscale asks how well informed the respondent is about the domains of decision makers, 
flexibility, and asking questions (quality of life is not part of this subscale).  The 
contemplation subscale asks how much the respondent has thought about items in each 
subscale.  The self-efficacy subscale asks how confident the respondent is that they could 
do these actions on that day.  Finally, the readiness subscale asks how ready the 
respondent is to do these actions on that day. 
The decision makers domain includes ten questions about identification of a 
surrogate decision maker and informing them and the providers of the responsibility.  The 
quality of life domain is divided into health situations (seven questions) and medical care 
at the end of life (nine questions) and includes questions about the identification of the 
person’s values and goals and communicating them to the surrogate and provider.  The 
flexibility domain includes six process measure questions about communicating the 
amount of leeway the surrogate will have in making decisions.  Finally, the asking 
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questions domain includes two questions asking the respondent about preparedness to ask 
providers questions in order to make informed care decisions.   
The overall Cronbach’s alpha for the 34-question ACPES is 0.96 (Sudore et al., 
2017), with intra-class correlations ranging from 0.54 – 0.82 (Sudore et al., 2013).  One-
week test-retest intraclass correlation (ICC) was used to estimate the survey’s reliability; 
this test indicates whether the survey measures the outcome the same way, in a stable 
study participant, each time it is used (Tabachnick & Fidell, 2012).  ICC values over 0.8 
indicate almost perfect agreement; ICC values of 0.7 to 0.8 indicate strong agreement; 
and ICC values of 0.5 to 0.6 indicate moderate agreement.  The ICC for the ACPES was 
0.70 for process measures overall (Sudore et al., 2013).  For each subscale of knowledge, 
contemplation, self-efficacy, and readiness, the one-week test-retest ICCs were 0.70, 
0.56, 0.60, and 0.69, respectively (Sudore et al., 2013).  Cronbach’s alpha was also 
calculated to estimate internal consistency; this test should have a value above 0.7 
(Tabachnick & Fidell, 2012).  Cronbach’s alpha was calculated as 0.96 for the process 
measures overall (Sudore et al., 2013).  It was calculated as 0.84, 0.86, 0.83, and 0.92 for 
each subscale of knowledge, contemplation, self-efficacy, and readiness, respectively 
(Sudore et al., 2013).  
ACCF/AHA Heart Failure Stage and NYHA Heart Failure Class 
 ACCF/AHA heart failure stage and NYHA heart failure class are routinely 
documented by OHVC providers during the usual course of patient care.  ACCF/AHA 
Stage is based on objective information and gives providers data about physical changes 
in the heart, while NYHA Class is based upon a patient’s self-report of symptoms.  Both 
of these variables are used by providers to determine a patient’s treatment plan.  The 
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information on stage and class was retrieved from the medical record by the investigator 
during the initial screening of potential participants. 
Comorbidity 
 The independent variable comorbidity was measured using the Charlson 
Comorbidity Index (CCI) (Charlson, Pompei, Ales, & MacKenzie, 1987).  See Appendix 
B.  The CCI uses data collected from the medical record by the researcher, including both 
the patient’s age and the presence of certain other disease processes such as heart failure, 
cancer, and liver disease.  Each of the comorbid conditions measured in the CCI has a 
correlative ICD-10 code that can be queried within an electronic medical record. 
The CCI contains 17 categories of comorbidities that are assigned weights of one, 
two, three, or six points, based on the adjusted risk of mortality from that factor (Charlson 
et al., 1987).  Patients receive one point for each of the following disorders: myocardial 
infarction; heart failure; peripheral vascular disease; cerebrovascular accident with mild 
or no residual; dementia; chronic pulmonary disease; connective tissue disease; peptic 
ulcer disease; mild liver disease, without portal hypertension; diabetes without end-organ 
damage, unless diet-controlled; and age over 40 years, with one additional point given 
per decade.  Patients receive two points for each of the following disorders: diabetes with 
end-organ damage; hemiplegia or paraplegia; moderate or severe renal disease; and 
malignancies diagnosed within the previous five years, except skin. Patients receive three 
points for moderate or severe liver disease.  Finally, they receive six points for a 
metastatic tumor or a diagnosis of AIDS.  The overall CCI score reflects the increased 
likelihood of one-year mortality, with higher scores indicating higher risk.  The CCI has 
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been tested multiple times and demonstrates good test-retest and interrater reliability (De 
Groot, Beckerman, Lankhorst, & Bouter, 2003; Quan et al., 2011).   
Patient Perception of Health Status 
 Patient perception of health status was assessed based on participant responses to 
three questions.  The first question states “In general, would you say your health is:” and 
provides participants with five response options (excellent, very good, good, fair, or 
poor).  The second question states “Compared to a year ago, how would you rate your 
health in general now?” The response options range from “Much better” to “Much 
Worse” than one year ago.  The third question asks “How are you feeling today?” and 
gives five options ranging from excellent to poor. 
The first two questions were taken from the SF-36, an instrument widely 
validated to assess quality of life (Failde & Ramose, 2000; Jenkinson, Wright, & Coulter, 
1994; Ruta et al., 1994).  Recent tests of reliability and validity show an overall 
Cronbach’s Alpha coefficient of 0.791 (Zhang et al., 2012).  The third question was taken 
from pilot work that involved cognitive interviews with five patients to determine its 
feasibility in the heart failure population.  Three of the five patients indicated that their 
responses to the ACPES would depend on how they were feeling at the time they took the 
survey.  Each question was analyzed separately as described in chapter three. 
Recent Hospitalizations 
Participants were asked if they have been hospitalized within the last six months 
for more than an overnight stay.  This question had dichotomous yes/no responses for 
them to select. 
 
63 
Sociodemographic Variables 
 Patients received a background questionnaire (Appendix B) on which they were 
asked their age, gender, ethnicity, marital status, religious preference, and education 
level. 
 Income was assessed by asking two questions on the background questionnaire.  
Participants were first asked, “When you consider your total household income, would 
you say that you are comfortable, have just enough to make ends meet, or do NOT have 
enough to make ends meet?” and provided with those three options.  Second, they were 
asked their total annual household income before taxes and be provided with ranges from 
“under $25,000” to “over $100,000.”  Options of “unknown” and “decline to answer” 
were be provided. 
Health Literacy  
Health literacy was assessed using three questions on the background 
questionnaire.  The first question asked, “How confident are you filling out medical 
forms?” and provided participants with 5 response options (excellent, very good, good, 
fair, or poor).  The second question asked, “How often do you have problems learning 
about your medical condition because of difficulty understanding written information?”  
The final question was “How often do you have someone help you read hospital 
materials?”  These questions had five response options ranging from “almost all of the 
time” to “never.”  These questions have been previously used in surveys to identify 
patients with inadequate health literacy, and have been shown to be effective 
replacements for the Short Test of Functional Health Literacy in Adults (Chew, Bradley, 
& Boyko, 2004; Wallace et al., 2006). 
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Study Procedures 
Upon approval by the dissertation committee, the protocol was submitted to the 
Indiana University Institutional Review Board (IU IRB) for approval.  Once approved, 
the documentation was sent to the IRB of The Christ Hospital, but the IU IRB was the 
IRB of record.  Once IRB approval from The Christ Hospital was received, staff at 
OHVC ran an initial query to obtain names and medical record numbers of all current 
patients with a diagnosis of heart failure.  The study investigator then reviewed the 
electronic health record of all individuals seen by OHVC heart failure physicians for 
screening purposes only. The stratified sampling technique was used to ensure mailings 
went to potential participants in each heart failure stage.  Each participant was assigned a 
random identification number; a key to these numbers was retained to track participants 
that returned their questionnaires after the first mailing. 
A survey packet was prepared for each potential participant that had the patient’s 
randomly generated identification number.  Names were retained for the sole purpose of 
ascertaining those who needed reminder letters and delivering survey incentives.  As part 
of the survey packet, potential participants received an introductory letter from their 
cardiologist at OHVC that introduced the investigator and asked them to complete the 
study.  The packet also contained a letter of information about the study (Appendix A), 
the background questionnaire (Appendix B), and the ACPES (Appendix C).  The 
background questionnaire and ACPES were coded with the participants’ random 
identification numbers.  Participants were also informed about the study incentives: those 
who completed the survey within two weeks were entered into a drawing for three $50 
gift cards to a local grocer of their choice; those who returned the materials after the 
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reminder were entered into a drawing for three $25 gift cards to a local grocer of their 
choice.  The packet also contained a card for the participant to complete with their 
contact information for entry into the gift card drawings.  The packets were sent via U.S. 
mail, along with a postage-paid return envelope.   
Returned surveys were checked against the key to determine those who had not 
responded within two weeks.  Participants who did not return the study materials within 
two weeks received a reminder letter and a second copy of the materials.  Packets 
returned to sender were checked for address accuracy, but new addresses were not 
available for any of them.  They were thus removed from the participant list.   
Data Analysis 
 Analysis for each study aim was performed using SPSS.  The level of statistical 
significance for all analyses was set at p ≤ .05 to decrease the risk of Type 1 error.  Type 
1 errors occur when a correct null hypothesis is rejected (Tabachnick & Fidell, 2013).  
Because there were multiple hypotheses to be tested in this study, the likelihood of a 
Type 1 error increased.  This would result in a false finding of statistical significance.  
Adjusting the p value, such as through the Bonferroni method, decreases the chance of a 
Type 1 error, but necessitates an increase in sample size or increases the likelihood of a 
Type 2 error (Feise, 2002).  In this study, the rate of return was sufficient to produce a 
sample size large enough to preserve power with the Bonferroni adjustment applied. 
The independent variables in this study were ACCF/AHA stage, CCI, recent 
hospitalizations, age, gender, ethnicity, marital status, income, education level, religion, 
and health literacy level.  Table 3 illustrates how the data was reported and entered for 
statistical analysis. 
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Table 3: Predictor Variables 
Predictor Variable Type of 
Variable 
Response Coding 
ACCF/AHA Stage Categorical  A, B, C, or D 
NYHA Class Categorical 1, 2, 3, or 4 
CCI Continuous 0–28 
Recent hospitalizations Dichotomous, 
categorical 
0 = no 
1 = yes 
Age Categorical  0 = under 40 
1 = 41 to 50 
2 = 51 to 60 
3 = 61 to 70 
4 = over 70 
Gender Categorical 0 = male 
1 = female 
Ethnicity Categorical 0 = African-American or Black 
1 = Caucasian or White 
2 = Asian 
3 = American Indian or Native 
Alaskan 
4 = Native Hawaiian or Pacific 
Islander 
5 = Hispanic or Latino 
Marital Status Categorical 0 = single 
1 = married 
2 = widowed or widower 
3 = divorced 
4 = living with partner 
Income range Categorical 0 = under $25,000 
1 = $25,000 –$49,999 
2 = $50,000 – $74,999 
3 = $75,000 – $9,999 
4 = $100,000 or more 
Making ends meet Categorical 0 = comfortable 
1 = just enough to make ends meet 
2 = not enough 
Education level Categorical 0 = grammar school 
1 = high school or equivalent 
2 = vocational or technical school 
3 = some college 
4 = Bachelor degree 
5 = Master’s degree 
6 = doctoral degree 
7 = professional degree 
Religion Categorical 0 = Protestant 
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Predictor Variable Type of 
Variable 
Response Coding 
1 = Catholic 
2 = other Christian 
3 = Mormon 
4 = Jewish 
5 = Muslim 
6 = other non-Christian religion 
7 = no religion 
Key: ACCF = American College of Cardiology Foundation; AHA = American Heart 
Association; CCI = Charlson Comorbidity Index; NYHA = New York Heart Association. 
 
The dependent variable in this study was engagement in ACP as measured by the 
ACPES.  Numerical values were assigned to the 5-point Likert.  A total process measure 
score was calculated, with a range from 31 to 155 points.  Total scores for each subscale 
of knowledge, contemplation, self-efficacy, and readiness were also calculated, with 
ranges of 6 to 30 points, 9 to 45 points, 6 to 30 points, and 10 to 50 points, respectively. 
Initial analysis consisted of the calculation of descriptive statistics for all 
variables.  For independent variables, this assisted in evaluating the quality of the data 
and to identify any patterns of missing and out-of-range values.  CCI, a continuous 
variable, was reported as mean (M) and standard deviation (SD).  Frequency and 
percentages of the categorical variables (ACCF/AHA stage, recent hospitalizations, age, 
gender, ethnicity, marital status, income, education level, religiosity, and health literacy 
level) were calculated.  The process measures were described using mean and standard 
deviation, overall and for each subscale. 
Specific Aim 1 examined characteristics of the patients participating in the study. 
Aim 1A: What are the characteristics of patients who are participating in this 
study of advance care planning?  Descriptive statistics were run on each independent 
variable (see Table 5). 
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Aim 1B: What percentage of patients in this study report having appointed a 
surrogate decision-maker for health care decisions?  The background questionnaire 
included the following questions: “Have you already formally asked someone to be your 
medical decision maker” and “Have you signed official papers naming a person or group 
to make medical decisions for you?”  Frequencies and percentages of yes and no 
responses were tabulated and reported. 
Aim 1C: What percentage of patients in this study report discussions of values 
and goals of care with surrogate decision-makers?  The background questionnaire 
included the following questions: “Have you talked with your medical decision maker 
about whether certain health situations would make your life not worth living,” and 
“Have you talked to your medical decision maker about how much flexibility you want to 
give her/him?”  Frequencies and percentages of yes and no responses were tabulated and 
reported. 
Aim 1D.  What percentage of patients in this study report discussions of values 
and goals of care with healthcare providers?  The background questionnaire included the 
following questions: “Have you talked to your doctor about who you want your medical 
decision maker to be,” and “Have you talked with your doctor about whether certain 
health situations would make your life not worth living?”  Frequencies and percentages 
of yes and no responses were tabulated and reported. 
Aim 1E: What percentage of patients in this study report having completed 
advance directives?  The background questionnaire included the following questions: 
“Have you signed official papers naming a person or group to make medical decisions for 
you;” “Have you signed official papers about your wishes for medical care if you were 
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seriously ill or dying;” and “Have you signed official papers to put your wishes about 
how much flexibility to give your decision maker in writing?”  Frequencies and 
percentages of yes and no responses were tabulated and reported. 
For each subsection of Aim 1, frequencies and percentages of yes and no 
responses were further broken down by the four ACCF/AHA stages A, B, C, and D to 
assess frequency and percentage of each behavior in each stage of heart failure.   
Specific Aim 2 examined the strength of association between engagement in 
advance care planning and several variables. 
Aim 2A.  What is the strength of the association between engagement in advance 
care planning and ACCF/AHA heart failure stage? 
Aim 2B.  What is the strength of the association between engagement in advance 
care planning and NYHA heart failure class? 
Aim 2C.  What is the strength of the association between engagement in advance 
care planning and patient comorbidities? 
Aim 2D.  What is the strength of the association between engagement in advance 
care planning and patient perception of health status? 
Aim 2E.  What is the strength of the association between engagement in advance 
care planning and any recent hospitalizations? 
Aim 2F.  What is the strength of the association between engagement in advance 
care planning and making healthcare decisions for others? 
Aim 2G.  What is the strength of the association between engagement in advance 
care planning and the sociodemographic variables of age, gender, ethnicity, marital 
status, income, education, religion, and health literacy? 
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For Aim 2, a regression analysis was conducted to assess if the independent 
variables heart failure stage, heart failure class, comorbidity index, patient perception of 
health status, and recent hospitalizations predict the dependent variable engagement in 
advance care planning.  A review of the research does not elicit any information about the 
order of the predictor variables or about the importance of them in relation to the 
dependent variable advance care planning.  The assumptions of multiple regression 
include linearity, independence of residuals, homoscedasticity, and absence of 
collinearity.  When the assumptions are not met, the results may result in Type I or Type 
II errors, or over- or under-estimation of effect size.   
Linearity assumes a straight-line relationship between the predictor variables and 
the dependent variable, and was tested by a scatter plot.  Independence of errors means 
that errors are independent of one another, which indicates that participants are 
responding independently, and was assessed by plotting the studentized deleted residuals 
against the predicted values.  A pattern that is not random suggests a lack of 
independence of errors.  Homoscedasticity refers to equal variance of errors for all values 
of the predictor variables and was assessed by scatter plots of the residuals.  Finally, the 
absence of collinearity assumes that predictor variables are independent from each other 
and thus allows the researcher to interpret the regression coefficients as the effects of the 
predictor variables on the dependent variable.  Collinearity was assessed using Variance 
Inflation Factors (VIF) in SPSS.  VIF values of 1 indicate a lack of collinearity between 
factors, while any value over 1 indicates some correlation.  VIF values over 10 will 
suggest high correlation between the factors, and potentially problematic collinearity.  If 
variables violate the assumption of collinearity, there are methods of adjustment, 
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including removing highly correlated predictors from the model.  Such predictors would 
be indicated by high VIF values and could imply redundant information.  Other options 
would be to use principal components analysis to construct factor scores, which are 
orthogonal, from the collinear variables. In addition, diagnostic plots of residuals and 
measures of influence (for example, Cook’s distance) will be produced to identify 
potential outlying and influential observations.  Such outliers may merely be extreme 
values of a variable, and thus should be retained.  However, they may be the result of an 
error in calculation or even data collection.   
The F-test was used to test the linear association between the set of independent 
variables collectively and the dependent variable.  R-squared (the multiple correlation 
coefficient of determination) was reported and used to determine proportion of variance 
in engagement accounted for by the set of independent variables (ACCF/AHA stage, 
comorbidity index, patient perception of health status, and recent hospitalizations).  
Adjusted R-squared was also calculated, as this value accounts for the number of 
independent variables and sample size, and thus is more reflective of generalizability to 
the population.  Beta coefficients were used to determine the magnitude of linear 
association for each independent variable.   
Bivariate measures of association appropriate for the level of measurement were 
reported for the continuous predictor with each independent variable.  Chi-square tests 
were calculated and reported to accomplish the same for all pairs of independent and 
dependent categorical variables.  Multiple linear regression was used to determine the 
degree to which independent variables predict engagement in advance care planning 
when controlling for all other independent variables. 
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CHAPTER 4 
RESULTS 
The purpose of this study was to gain knowledge about engagement in advance 
care planning in participants diagnosed with heart failure and to evaluate the impact of 
certain variables (ACCF/AHA heart failure stage; comorbidity index; participant 
perception of health status; recent hospitalizations; and the sociodemographic variables of 
age, gender, ethnicity, marital status, income, education, and religiosity) on engagement 
in advance care planning.  This chapter reports the results from the study. 
Specific Aims and Hypothesis Testing 
Aim 1 
Question 1A: What are the characteristics of the patients who are participating in 
this study of advance care planning? 
The population examined consisted of adult participants who were seen by the 
physicians at Ohio Heart and Vascular Center in Cincinnati, Ohio between July 2016 and 
May 2018.  A total of 1067 surveys were mailed to 716 potential study participants, of 
which 233 were returned, resulting in a response rate of 32.6%.  The mailings were 
intended to evenly stratify participants by stage; however, there were not enough 
potential participants in Stage D to construct groups of the same size.  In order to increase 
the total number of surveys mailed, additional participants from Stage C received surveys 
because this was the next closest stage in severity.  The initial mailing included 125 
participants in Stage A, 125 in Stage B, 192 in Stage C, and 58 in Stage D.  A second 
mailing was sent to 363 nonresponders from the initial sample along with 140 new 
participants.  A third mailing was added and the survey was sent to 67 new participants.   
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A chi-square goodness of fit test was used to compare responders and 
nonresponders as to heart failure stages and classes.  Statistically significant differences 
were seen when comparing responders and non-responders as to heart failure stage, X2 
(3, N = 706) = 97.128, p < 0.01, and as to heart failure class, X2 (7, N = 706) = 140.6, p < 
0.01. There was no statistically significant difference between responders and non-
responders as to gender, X2 (1, N = 706) = 0.5495, p = 0.46.  Table 4 shows the chi-
square and significance values for the responders and nonresponders with respect to 
gender, Stage, and Class.  Because only six of the study participants were in Stage D 
heart failure, their data were combined with those in Stage C for all of the analyses. 
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Table 4: Comparison of Survey Responders’ and Nonresponders’ Characteristics 
 Total 
n = 706 
n (%) 
Responders 
n = 233 
n (%) 
Nonresponders 
n = 483 
n (%) 
Chi-square 
test 
Gender     
Male 383 (54.2) 120 (31.3) 263 (68.7) X2 = 0.55 
Female 323 (45.8) 113 (35.2) 220 (64.8) p = 0.46 
     
ACCF/AHA Heart 
Failure Stage 
    
A 132 (18.7) 11 (8.3) 121 (91.7)  
B 207 (29.3) 59 (28.5) 148 (71.5)  
C 308 (43.6) 157 (51.1) 151 (48.9) X2 = 97.13 
D 59 (8.4) 6 (10) 53 (90) p < 0.01 
     
NYHA Heart 
Failure Class 
    
N/Aa 132 (18.7) 11 (8.3) 121 (91.7)  
1 204 (28.9) 59 (28.9) 145 (71.1)  
1–2 12 (1.7) 9 (75) 3 (25)  
2 151 (21.4) 86 (57.2) 65 (42.8)  
2–3 73 (10.3) 15 (20.5) 58 (79.5)  
3 74 (10.5) 47 (63.5) 27 (36.5)  
3–4 3 (0.4) 1 (33.3) 2 (66.7) X2 = 140.6 
4 57 (8.1) 4 (7) 53 (93) p < 0.01 
Key: ACCF/AHA = American College of Cardiology Foundation/American Heart 
Association.  NYHA = New York Heart Association.   
Notes: a Stage A participants have no symptoms and thus are not assigned to a NYHA 
Heart Failure Class. 
 
Slightly more than half (51.5%, n=120) of the participants were male, with the 
majority of the participants over age 70 (57.5%, n=134) and married (56.7%, n=132).  
The majority of the participants (56.2%, n=131) identified as Caucasian or white, with 
39% (n=91) identifying as African American or black.  The majority (73.4%, n=171) of 
participants had at least some college education and identified as Christian (86.7%, 
n=202).  Table 5 summarizes participant demographic characteristics. 
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Table 5: Demographic Characteristics of Participants 
Characteristic (n=233) n (%) 
Gender  
Male 120 (51.5) 
Female 113 (48.5) 
Age   
41 – 50 years 12 (5.2) 
51 – 60 years 27 (11.6) 
61 – 70 years 55 (23.6) 
Over 70 years 134 (57.5) 
Race  
African American or black 92 (39) 
Caucasian or white 132 (56.2) 
Asian 9 (3.8)  
Not Hispanic/Latino 209 (89.7) 
Marital Status  
Married 132 (56.7)  
Single 37 (15.9) 
Widowed/widower 32 (13.7) 
Divorced 31 (13.3) 
Income  
Comfortable 119 (51.1) 
Just enough to make ends meet 75 (32.2) 
Not enough to make ends meet 31 (13.3) 
  
Under $24,999 35 (15) 
$25,000 to $49,999 52 (22.3) 
$50,000 to $74,999 29 (12.4) 
$75,000 to $100,000 23 (9.9) 
Over $100,000 43 (18.5) 
Education   
Grammar school 3 (1.3) 
Vocational/technical school (2 year) 6 (2.6) 
High school or equivalent 44 (18.9) 
Some college 65 (27.9) 
Bachelor degree 49 (21) 
Master’s degree 29 (12.4) 
Doctoral or professional degree 28 (11) 
Residence  
Urban 65 (27.9) 
Suburban 148 (63.5) 
Rural 20 (8.6) 
Religion  
Protestant 80 (34.3) 
Catholic 90 (38.6) 
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Characteristic (n=233) n (%) 
Other Christian  32 (13.7) 
Jewish 2 (0.9) 
No religion 15 (6.4) 
 
 The participants were also asked about their current health status and rated it from 
excellent to poor.  A majority rated their health as fair or better (84%, n=193).  The 
participants also reported their health status compared to one year ago, and the majority 
(70.9%, n=163) reported that it was about the same.  They were also asked about how 
they were feeling the day they took the survey, from excellent to poor, and a majority 
(41.3%, n=95) stated that they felt fair, with another 38.7% (n=89) stating they felt good.  
About half (52.8%) had been hospitalized for more than an overnight stay within the past 
six months.  Table 6 presents the details of these characteristics of the study participants.   
Table 6: Self-Reported Health Status of Participants  
Characteristic (n=230) n (%) 
Current Health Statusa  
Excellent 2 (0.9) 
Very good 16 (7) 
Good 75 (32.6) 
Fair 100 (43.5) 
Poor 37 (16.1) 
Health Compared to 1 Year Priora   
Much better 2 (0.9) 
Somewhat better 5 (1.5) 
About the same 163 (70.9) 
Somewhat worse 54 (23.5) 
Much worse 6 (2.6) 
How Feeling Todayb  
Excellent 2 (0.9) 
Very good 17 (7.4) 
Good 89 (38.7) 
Fair 95 (41.3) 
Poor 26 (11.3) 
Hospitalization During Last 6 Months 123 (52.8) 
Notes. aThe first two questions were taken from the SF-36 measure (Ware & Sherbourne, 
1992). bThe third question was added based on cognitive interviews based on pilot work 
done by the researcher. 
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Most of the study participants reported adequate health literacy skills and 
confidence in learning about their health conditions.  A majority (42.2%, n=97) reported 
their confidence in completing medical forms as excellent, with another 28.3% (n=65) 
reporting their confidence as very good.  When asked if they had difficulty understanding 
medical information, 28.2% (n=64) reported they never had difficulty, with another 
43.6% (n=99) stating they rarely had difficulty.  The majority (47.6%, n=109) of 
participants also stated that they never had to have someone help them read.  These data 
are summarized in Table 7. 
Table 7: Health Literacy of Participants 
Characteristic n (%) 
Confidence in Completing Forms (n=230)  
Excellent 97 (42.2) 
Very good 65 (28.3) 
Good 47 (20.4) 
Fair 13 (5.7) 
Poor 8 (3.5) 
Difficulty Understanding (n=227)  
Never 64 (28.2) 
Rarely 99 (43.6) 
Occasionally 47 (20.7) 
Frequently 14 (6.2) 
Almost all of the time 3 (1.3) 
Have Someone Help You Read (n=229)  
Never 109 (47.6) 
Rarely 65 (28.4) 
Occasionally 29 (12.7) 
Frequently 19 (8.3) 
Almost all of the time 7 (3.1) 
Note: Scores on the three questions were averaged for statistical analysis. 
 
Question 1B: What percentage of participants with heart failure in this study 
report having appointed a surrogate decision-maker for healthcare decisions? 
 The majority of participants in this study (59.7%, n=139) reported that they have 
formally asked someone to be a surrogate decision-maker (SDM) for healthcare 
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decisions; 97.1% of those participants (n=135) have already signed official documents.  
Only 10.7% (n=25) reported that they had never thought about it.  A chi-square test of 
independence was performed to examine the relation between heart failure stage and 
asking someone to be an SDM.  The relationship between these variables was not 
statistically significant, X2 (8, N = 232) = 9.206, p = 0.33.  Table 8 summarizes the data 
related to the appointment of a surrogate decision-maker. 
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Table 8: Appointment of Surrogate Decision-Maker by Heart Failure Stage 
 Total 
(n=233) 
A 
n=11 
n (%) 
B 
n=59 
n (%) 
C & D 
n=163 
n (%) 
Status of Appointment     
Already formally 
asked 
139 (59.7) 5 (45.5) 36 (61) 99 (71.2) 
Planning to formally 
ask within next 30 
days 
4 (1.7) 0 (0) 0 (0) 4 (2.5) 
Thinking about 
formally asking 
within next 6 
months 
16 (6.9) 1 (9) 3 (5.1) 12 (7.4) 
Thought about 
formally asking, but 
not ready to do it 
49 (20.6) 5 (45.5) 15 (25.4) 29 (17.8) 
Never thought about 
formally asking 
25 (10.7) 0 (0) 5 (8.5) 20 (12.3) 
Official Documents     
Already signed 
official papers 
135 (57.9) 4 (36.4) 35 (59.3) 96 (58.9) 
Planning to sign 
papers within 30 
days 
5 (2.1) 1 (9.1) 0 (0) 4 (2.5) 
Thinking about 
signing official 
papers within next 6 
months 
35 (15) 2 (18.2) 10 (16.9) 23 (14.1) 
Thought about 
signing official 
papers, but not 
ready to do it 
30 (12.4) 4 (36.4) 6 (10.2) 20 (12.2) 
Never thought about 
signing official 
papers 
28 (12) 0 (0) 8 (13.6) 20 (12.2) 
 
Question 1C: What percentage of participants in this study report discussions of 
values and goals of care with surrogate decision-makers? 
The majority of participants in this study (56%, n=130) reported that they have 
discussed their goals of care with their surrogate decision-makers (SDM).  Nineteen 
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percent (n=44) reported that they had never thought about it.  When broken down by HF 
stage, 36.4% (n=4) of participants with Stage A have discussed their goals of care with 
their surrogate decision-makers, with 57.1% (n=32) in Stage B, 60% (n=90) in Stage C, 
and 66.7% (n=4) in Stage D having done so.  A chi-square test of independence was 
performed to examine the relation between heart failure stage and discussions of goals of 
care with their SDM.  The relationship between these variables was significant, X2 (8, N 
= 222) = 28.304, p <.01, indicating that there is a statistically significant relationship 
between heart failure stage and whether or not someone has discussed their goals of care 
with a surrogate decision-maker.  Table 9 summarizes the data related to the discussion 
of goals of care with a surrogate decision-maker. 
Table 9: Discussion of Values and Goals of Care with Surrogate Decision-Makers by 
Heart Failure Stage 
 Total 
(n=223) 
A 
n=11 
n (%) 
B 
n=56 
n (%) 
C & D 
n=156 
n (%) 
Status of Discussion     
Already done 130 (58.3) 4 (36.4) 32 (57.1) 94 (60.3) 
Planning to do it 
within next 30 days  
4 (1.8) 1 (9.1) 1 (1.8) 2 (1.3) 
Thinking about doing 
it within next 6 months 
24 (10.8) 2 (18.2) 5 (8.9) 17 (10.9) 
Thought about doing 
it, but not ready  
29 (13) 3 (27.3) 7 (12.5) 19 (12.2) 
Never thought about 
doing it 
44 (19.7) 1 (9.1) 15 (26.8) 28 (17.9) 
 
Question 1D: What percentage of participants with heart failure in this study 
report discussions of values and goals of care with healthcare providers? 
The majority of participants in this study (87.9%, n=173) stated that they have not 
discussed their goals of care with their healthcare providers, although 26.1% (n=58) were 
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planning to do it within the next six months.  Thirty-one percent (n=69) reported that they 
had never thought about it.  A chi-square test of independence was performed to examine 
the relation between heart failure stage and discussion of goals of care with providers, 
and the relationship between these variables was significant, X2 (8, N = 212) = 20.659, p 
<.01. This indicates that there is a statistically significant relationship between heart 
failure stage and whether or not someone has discussed their goals of care with their 
healthcare providers.  None of the participants in Stage A reported having discussed their 
goals of care with their providers, compared to 10.7% (n=6) in Stage B and 27.6% (n=43) 
in Stages C & D.  Table 10 summarizes the data related to the discussion of goals of care 
with a healthcare provider. 
Table 10: Discussion of Values and Goals of Care with Provider by Heart Failure Stage,  
 Total 
(n=222) 
A 
n=10 
n (%) 
B 
n=56 
n (%) 
C & D 
n=156 
n (%) 
Status of Discussion     
Already done 49 (22.1) 0 (0) 6 (10.7) 43 (27.6) 
Planning to do it within 
next 30 days 
6 (2.7) 0 (0) 1 (1.8) 5 (3.2) 
Thinking about doing it 
within next 6 months 
52 (23.4) 5 (50) 18 (32.1) 29 (18.6) 
Thought about doing it, 
but not ready  
46 (20.7) 1 (10) 5 (8.9) 40 (25.6) 
Never thought about 
doing it 
69 (31.1) 4 (40) 26 (46.4) 38 (25.6) 
 
Question 1E: What percentage of participants with heart failure in this study 
report having completed advance directives? 
The majority of participants in this study (56.9%, n=121) reported having 
completed advance directives, and an additional 15.6% (n=34) are planning to complete 
them within the next six months.  Thirty-six percent (n=4) of participants with Stage A 
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have discussed their goals of care with their surrogate decision-makers, with 48.5% 
(n=32) in Stage B, and 56.3% (n=85) in Stage C, and 83.3% (n=5) in Stage D reporting 
these discussions.  A chi-square test of independence was performed to examine the 
relation between heart failure stage and discussion of goals of care with providers, and 
the relationship between these variables was not statistically significant, X2 (8, N = 217) 
= 11.147, p = 0.19, showing that there is not a statistically significant relationship 
between heart failure stage and whether or not someone has completed advance 
directives.  This indicates that heart failure stage is not associated with the completion of 
advance directives; the different failure stages had similar odds for completing advanced 
directives.  Table 11 summarizes the data related to the completion of advance directives. 
Table 11: Completion of Advance Directives by Heart Failure Stage,  
 Total 
(n=218) 
A 
n=11 
n (%) 
B 
n=56 
n (%) 
C & D 
n=151 
n (%) 
Status of Completion     
Already done 121 (56.9) 4 (36.4) 32 (48.5) 85 (56.3) 
Planning to do it 
within next 30 days  
5 (2.3) 1 (9.1) 1 (1.8) 3 (2.0) 
Thinking about doing 
it within next 6 months 
29 (13.3) 2 (18.2) 4 (7.1) 23 (15.2) 
Thought about doing 
it, but not ready  
40 (18.3) 4 (36.4) 14 (25) 22 (14.6) 
Never thought about 
doing it 
23 (10.6) 0 (0) 5 (8.9) 18 (11.9) 
 
Aim 2 
An ANOVA (analysis of variance) was performed to examine the relationship 
between the dependent variable of engagement score as measured by the Advance Care 
Planning Engagement Survey (ACPES) and the independent variables of Stage, CCI 
(Charlson Comorbidity Index), participant perception of health status, and 
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hospitalizations.  A statistically significant association was found between the 
combination of these independent variables and the engagement score, F (4,181) = 6.591, 
p <.01.  Each variable was also examined independently.  Small cell sizes did not allow 
statistical testing of interaction effects. 
Question 2A: What is the strength of the association between engagement in 
advance care planning and ACCF/AHA heart failure stage? 
An ANOVA was performed to examine the relationship between the engagement 
score and heart failure stage.  The ANOVA showed that there was no statistically 
significant association between stage and the engagement score, F (1,187) = 0.966, p = 
0.33, indicating that ACCF/AHA heart failure stage is a poor predictor of engagement in 
advance care planning.   
Question 2B: What is the strength of the association between engagement in 
advance care planning and NYHA heart failure stage? 
An ANOVA was performed to examine the relationship between the engagement 
score and heart failure class.  The ANOVA showed that there was no statistically 
significant association between class and the engagement score, F (1,187) = 0.031, p = 
0.70, indicating that people in different NYHA heart failure classes had similar 
engagement scores.   
Question 2C: What is the strength of the association between engagement in 
advance care planning and participant comorbidities? 
An ANOVA was performed to examine the relationship between the engagement 
score and participant comorbidities, as quantified by the Charlson Comorbidity Index 
(CCI).  The ANOVA showed that there was a statistically significant association between 
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the dependent variable CCI and the engagement score, F (1,187) = 9.767, p < .01.  CCI is 
thus a significant predictor of engagement in advance care planning.   
Question 2D: What is the strength of the association between engagement in 
advance care planning and participant perception of health status? 
An ANOVA was performed to examine the relationship between the engagement 
score and each question participants were asked that pertained to health status.  For the 
first question, participants were asked to rate their general state of health as excellent, 
very good, good, fair, or poor.  The majority of participants (46.8%, n=87) rated their 
health as fair.  The ANOVA showed that there was no statistically significant association 
between how a person rated their health status and the engagement score, F (4,181) = 
0.506, p = 0.73.  There was, however, a significant association between how a person 
rated their health as compared to one year prior, F (4,181) = 3.090, p < 0.05.  Post hoc 
analyses were performed using Tukey HSD.  Statistically significant differences were 
found between those participants rating their current health status as about the same and 
those rating it as somewhat worse.  Those rating it about the same had higher mean 
engagement scores (127.5) than those rating it as somewhat worse (107.2).  Finally, when 
asked about how they were feeling that day, participants rated themselves as feeling 
excellent, very good, good, fair, or poor.  A majority (42.5%, n=79) stated they were 
feeling fair, closely followed by 40.3% (n=75) stating they were feeling good.  The 
ANOVA showed that there was no statistically significant association between how a 
person was feeling that day and the engagement score, F (4,181) = 1.119, p = 0.35.  A 
person’s perception of health status was therefore not found to be a significant predictor, 
in general, of engagement in ACP. 
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Question 2E: What is the strength of the association between engagement in 
advance care planning and any recent hospitalization? 
An ANOVA was performed to examine the relationship between the engagement 
score and the presence of any recent participant hospitalizations.  The ANOVA showed 
that there was not a statistically significant association between recent hospitalizations 
and the engagement score, F (1,187) = 0.883, p = 0.35.  The presence of recent 
hospitalizations is thus a poor predictor of engagement in advance care planning.   
Question 2F: What is the strength of the association between engagement in 
advance care planning and making healthcare decisions for others? 
Many participants (33.9%, n=79) reported that they had made healthcare 
decisions for others.  An ANOVA was performed to examine the relationship between 
the engagement score and making healthcare decisions for others.  The ANOVA showed 
that there was not a statistically significant association between the independent variable 
making healthcare decisions for others and the engagement score, F (1, 187) = 1.537, p = 
0.22. 
Question 2G: What is the strength of the association between engagement in 
advance care planning and the sociodemographic variables of age, gender, ethnicity, 
marital status, income, education, religion, and health literacy? 
An ANOVA was performed to examine the relationship between the engagement 
score and the sociodemographic variables of age, gender, ethnicity, marital status, 
income, education, religion, and health literacy.  The independent variables were isolated 
to determine which were statistically significant predictors.  Age, gender, ethnicity, 
marital status, education, and income were all found to have a statistically significant 
86 
association with engagement score.  The ANOVA showed that there was no significant 
association between engagement score and religion or between engagement score and 
health literacy. 
Data showed a statistically significant association between engagement score and 
age, F (3,185) = 4.978, p < .01, indicating that age is a variable that affects engagement 
in ACP.  Post hoc analyses were performed using Tukey HSD, which indicated 
statistically significant differences between the age group of over 70 and the age groups 
of 51–60 and 61–70.  Participants over age 70 had significantly higher engagement scores 
(M = 131.6, SD = 18.165) than those between the ages of 51–60 (M = 107.22, SD = 
46.302) and the ages of 61–70 (M = 114.4, SD = 38.726). 
A statistically significant association was also found between engagement score 
and gender, F (1,187) = 5.308, p < .05, indicating that gender is a variable that affects 
engagement in ACP.  Men had significantly higher engagement scores (M = 128.54, SD 
= 32.087) than women (M = 116.7, SD = 38.192) in this study. 
There was also a statistically significant association between engagement score 
and ethnicity, F (2,186) = 3.439, p < .05, indicating that ethnicity is a variable that affects 
engagement in ACP.  Post hoc analyses were performed using Tukey HSD.  Statistically 
significant differences were found between Asians and African-Americans, with Asians 
having higher engagement scores (M = 147.38, SD = 27.448) than African-Americans 
(M = 115.97, SD = 37.407).  However, only 8 participants identified as Asian. 
Statistically significant associations were also found between engagement score 
and marital status, F (3,185) = 6.9, p < .01.  This indicates that marital status is a variable 
that affects engagement in ACP.  Post hoc analyses were performed using Tukey HSD.  
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Statistically significant differences were found between the group of participants who 
were divorced and all other participants.  Participants who were divorced had 
significantly lower engagement scores (M = 97.86, SD = 50.826) than those who were 
single (M = 117.53, SD = 32.434), married (M = 129.1, SD = 30.399), or widowed (M = 
129.43, SD = 27.194). 
Education level was also found to be a variable that affects engagement in ACP, F 
(9,176) = 12.531, p < .01.  Post hoc analyses were performed using Tukey HSD.  
Statistically significant differences were found between several groups.  The group of 
participants who reported high school as the highest level of education had significantly 
lower engagement scores (M = 79.74, SD = 38.871) than those who reported education 
levels of vocational school (M = 116.5, SD = 15.0), some college (M = 128.4, SD = 
25.452), bachelor degree (M = 128.8, SD = 12.669), master’s degree (M = 144.16, SD = 
22.816), doctoral degree (M = 167.0, SD = 0), and professional degree (M = 137.3, SD = 
44.397).  Those who reported some college (M = 128.4, SD = 25.452) or bachelor 
degrees (M = 128.8, SD = 12.669) had engagement scores significantly lower than those 
with either master’s (M = 144.16, SD = 22.816) or doctoral degrees (M = 167.0, SD = 0). 
Self-reported income level was also found to be a variable that affects 
engagement in ACP, F (6,179) = 4.735, p < .01.  Post hoc analyses were performed using 
Tukey HSD.  Statistically significant differences were found between the income level of 
$75,000–$99,999 (M = 139.41, SD = 24.683) and the levels of $25,000–$49,999 (M = 
107.59, SD = 37.25) and $50,000–$74,999 (M = 104.71, SD = 45.088).  Statistically 
significant differences were also found between those declining to answer and the levels 
of $25,000–$49,999 (M = 107.59, SD = 37.25) and $50,000–$74,999 (M = 104.71, SD = 
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45.088).  There were also statistically significant differences between those declining to 
answer (M = 135.7, SD = 28.815) and those with income levels of $25,000–$49,999 (M = 
107.59, SD = 37.25) and $50,000–$74,999 (M = 104.71, SD = 45.088).   
In summary, this study demonstrates that comorbidity, age, gender, ethnicity, marital 
status, education, and income are all factors that are associated with engagement in ACP 
as measured by the ACPES.  Heart failure stage and class were not found to have 
statistically significant associations with engagement in ACP; nor were recent 
hospitalizations or making healthcare decisions for others. 
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CHAPTER 5 
DISCUSSION 
This was the first study to examine the impact of heart failure stage/class, 
comorbidities, recent hospitalizations, participant perception of health status, making 
healthcare decisions for others, and demographic variables on engagement in advance 
care planning (ACP).  Specifically, the purpose of this study was to determine the 
association between these variables and engagement in ACP, as measured by the 
Advance Care Planning Engagement Survey (ACPES).  This chapter reviews the findings 
of the current study and discusses how the findings support and advance the current 
science related to ACP.  Recommendations for practice and future research as well as 
study limitations are also described. 
Main Findings 
Although the main hypothesis of this study was that heart failure stage or class 
would be associated with engagement in ACP, the findings did not support it.  Findings 
from this study indicate that there are no significant associations between heart failure 
class or stage, recent hospitalizations, making healthcare decisions for others, or how a 
patient rated how they were feeling, and engagement in ACP.  However, comorbidity, as 
measured by the Charlson Comorbidity Index (CCI), was significantly associated with 
engagement in ACP in this study.  Among demographic variables, age, gender, marital 
status, and education level were also significant predictors of engagement in ACP.   
Heart Failure Stage/Class and Advance Care Planning Engagement 
 Prior to this study, the association between of heart failure stage or class and 
engagement in ACP was unknown. It was originally hypothesized that heart failure stage 
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and class would help to predict engagement in ACP because as the disease progresses, 
patients have more deleterious symptoms and have a poorer prognosis.  The likelihood of 
mortality from heart failure increases as a patient progresses through the stages, as do 
patient symptoms, because of irreversible changes to the heart structure.  Similarly, 
patient symptoms are assessed through heart failure class, and patient progression 
through the classes indicates that patients are more likely to have symptoms that 
negatively impact their quality of life, including shortness of breath and inability to 
perform normal daily activities.  However, we found no association between heart failure 
stage or class and engagement in ACP.  One possibility for this lack of association is that 
the cardiology practice routinely discussed advance care planning with patients. 
Comorbid Conditions’ Effect on Advance Care Planning Engagement 
  This study demonstrated that comorbid conditions, as measured by the CCI, were 
a statistically significant predictor of engagement in ACP as measured by the ACPES.  In 
practical terms, the study showed that a patient’s overall health (as measured by the 
presence of comorbidities), may be a way to determine a patient’s level of engagement in 
ACP; the greater the number of comorbidities, the more engaged the patient is likely to 
be in ACP.  This is significant because comorbidities are found within the medical record 
and can be easily identified to help target patients who may be ready to receive 
interventions on ACP.  With electronic medical records, the presence of certain comorbid 
conditions could trigger alerts to prompt the delivery of certain interventions.  For 
instance, this study indicates that people with multiple comorbid conditions are more 
likely to be at a higher level of engagement, and thus further along the stages of change, 
with regard to ACP.  Those with fewer, or no, comorbid conditions, are less likely to be 
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engaged in ACP, and thus would be in earlier stages of the TTM, such as pre-
contemplation. 
This finding is consistent with the existing literature, which indicates that patients 
with higher numbers of comorbid conditions are more likely to have ACP documented in 
their medical records, especially those with heart failure or chronic obstructive 
pulmonary disease (COPD) (Bond et al., 2018).  Other studies have shown that the odds 
of ACP documentation, consisting of either advance directives or discussions of care 
goals, increased with the presence of comorbid chronic illnesses such as heart disease, 
diabetes, and cancer (De Gendt, Bilsen, Stichele, and Deliens, 2013; Hash, Bodnar-
Deren, Leventhal, and Leventhal, 2016; Meeusen et al., 2011).  These studies, however, 
examine only the action phase of ACP, and thus cannot be directly compared. 
 In contrast, Barkley and colleagues (2018) found no significant association 
between CCI and ACP status when retroactively reviewing medical records.  
Documentation of ACP status in that study was limited to having an advance directive in 
the medical record, having discussion of it in progress notes, or having no ACP 
information at all.  This limited assessment of medical records examined only the action 
stage of ACP, which could be the reason for the contradictory results; patients may not 
have provided advance directives and the providers may not have noted discussions in the 
progress notes.  Additionally, the study examined only the end result of the ACP process 
rather than examining engagement as a whole.   
Similarly, David et al. (2018) found that lower CCI levels were associated with 
higher engagement scores on the ACPES.  However, one reason for the discrepancy 
between the findings of our research and the David et al., study is that David et al. used a 
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shortened form of the CCI, with only five intervals ranging from no comorbidity to 
severe comorbidity.  Our research used the original CCI as ratio data with a range from 
zero to twenty-eight points, and the majority of the participants had CCI scores over four.  
The comorbidity scoring was thus more specific than the dichotomous division used by 
David et al.  Additionally, the patient populations are different, as the participants in 
David’s research had to have had at least two chronic conditions and had either an 
emergency room visit or hospital admission within the previous year to qualify for the 
study.  Our research also includes participants that have no comorbid conditions other 
than heart failure, or a precursor to it.  These variables may have impacted David’s 
results, making it less comparable to the current study. 
Recent Hospitalizations 
Howard et al. (2016) recruited patients from a hospital, cancer care center, 
dialysis care center, and primary care clinics and found that the currently hospitalized 
patients had the highest scores on the ACPES, which is unsurprising given that patients 
are asked if they want to complete advance directive documents upon hospital admission.  
Our study recruited patients in the community and hospitalization data was based on a 
recall of experiences over the past two years.  Approximately one-half of the survey 
responders reported that they had been hospitalized in the previous two years, but this 
experience was not found to be significantly associated with engagement in ACP.  This 
lack of association could indicate that the impact of being asked about advance directives 
and surrogate decision-makers upon admission to a hospital does not extend beyond the 
hospitalization itself.   
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Making Healthcare Decisions for Others 
 There is minimal information available about the impact of making healthcare 
decisions for others on a person’s own engagement in ACP.  Prior research has shown 
that the serious illness of a family member or friend prompts people to pursue advance 
care planning for themselves, but did not specify whether this was necessarily in response 
to making decisions for that person (Levi, Dellasega, Whitehead, & Green, 2010; van 
Wijmen, Pasman, Widdershoven, & Onwuteaka-Philipsen, 2014).  The hypothesis that 
there would be an association between the two variables was based upon the conceptual 
theory on stages of change, which describes information as the impetus for moving from 
the precontemplation stage to the contemplation stage.  It followed that experience being 
a surrogate decision-maker would result in people being more engaged in their own ACP, 
but the current study found no significant association between these two variables.  It is 
possible that age factors into this variable, as those who are older will be more likely to 
have experienced a friend or family member dying from a serious illness.  The majority 
of participants in the current study were over age 60.  A better way to assess this variable 
may have been to ask about experiences with friends or family dying after a prolonged 
serious illness rather than asking about making the decisions for others. 
Patient Perception of Health Status 
 Patient perception of health status was assessed using three different strategies, 
but only one was statistically significant. Participant rating of their health status 
compared to one year prior was significantly associated with engagement in ACP, but the 
post hoc analyses indicate that those who considered their current health worse than one 
94 
year prior were actually less engaged in ACP than those who considered it about the 
same.   
When looking at rating their health at the present time, other studies found that 
those who considered themselves healthy were less likely to be engaged in ACP than 
those who did not (Hash et al., 2016; Howard, et al., 2016; Inoue, 2016; Tripken, J. L., 
Elrod, C., & Bills, S., 2016), but in the current study, this perception of health status was 
not statistically significant.   
Finally, this study examined how a patient was currently feeling to see if there 
was an association between that and engagement in ACP.  No research on this particular 
topic could be located, but in preparatory work, participants indicated that how they were 
feeling that day would change their answers to some of the ACPES questions.  This 
hypothesis was not supported by study findings.  
Sociodemographic Variables and Engagement in ACP 
Age, gender, marital status, education, and income.  This study also examined 
a number of sociodemographic variables to determine their association with ACP.  Age, 
gender, marital status, education, and income were all found to be significant predictors 
of engagement in ACP.  Increasing age increased engagement in ACP, which is 
consistent with prior research (Boucher, 2017; Dow et al., 2010; Fried et al., 2010; Inoue, 
2016; Reynolds, Hanson, Henderson, & Steinhauser, 2008).  Gender was also associated 
with engagement in ACP, with men having greater engagement scores than women in 
this study.  Prior research has mixed results in this area, with some finding men to be 
more engaged (Fried et al., 2010), some finding women to be more engaged (Boerner, 
Carr, & Moorman, 2016; Inoue, 2016), and some finding that gender did not affect ACP 
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(Sudore et al., 2008).  Those who were married also had higher rates of ACP, which is 
again consistent with prior research (Boerner, Carr & Moorman, 2013; Fried et al, 2010; 
Koss, 2017).   
Education level was a strong predictor of engagement in ACP, with higher 
education levels increasing engagement; this was consistent with prior research (Bullock, 
2011; Doyle, 2016; Muessen et al., 2011; Pereira-Salgado, Mader, & Boyd, 2018; 
Wagner et al., 2010).  Higher total household income levels were also associated with 
higher engagement scores in the current study, which is consistent with prior research 
(Alano et al., 2010; Dobalian, 2006; Doyle, 2016; Khosla, Curl, & Washington, 2016; 
Moorman & Inoue, 2013; Pollack et al., 2010).  One surprising finding in this study was 
that those in the lowest income bracket (less than $25,000 annually) had the second-
highest levels of engagement in ACP; this is inconsistent with prior research, and could 
be due to some of the study limitations discussed in chapter five. 
 Ethnicity.  Ethnicity was found to be a statistically significant predictor of 
engagement, but post-hoc results indicated that this was significant only between 
participants identifying as African-American or Asian.  Because only eight participants 
identified as Asian, the sample size is likely too small to generalize this finding.  There 
were no differences between African-Americans and Caucasians, a finding that is 
inconsistent with prior research.  Multiple studies have examined the effects of ethnicity 
on rates of ACP and have shown that in general, ethnic minorities have lower rates of 
ACP than Caucasians (Bullock, 2011; Carr, 2011; Dow et al., 2010; Guo et al., 2010; 
Huang, 2016; Reynolds et al., 2008).  Hypothesized reasons for these lower levels of 
ACP include lack of trust in the healthcare system, a focus on religiosity/spirituality, 
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disparities in communication about ACP and EOL care, and reliance on family members 
to make the “right” decisions (Carr, 2012; Car & Luth, 2017; McAfee, Jordan, Sheu, 
Dake, & Kopp Miller, 2017; Smith, McCarthy, Paulk, Balboni, Maciejewski, Block, & 
Prigerson, 2008).  In the current study, where there was no significant difference between 
Caucasians and African-Americans, it is likely that the results were skewed because of a 
standard practice of discussing ACP on at least an annual basis with every patient (see 
discussion in chapter five on limitations). 
Religious preference.  Religious preference was not found to be a statistically 
significant predictor of engagement in the current study.  Prior research has shown that 
religiosity/spirituality has an impact on specific ACP behaviors such as living wills and 
appointing a surrogate decision-maker (Garrido, Idler, Leventhal, & Carr, 2013; Janssen 
et al., 2016), but the current study assessed only religious preference rather than 
religiosity/spirituality.  Additionally, the sample was largely homogeneous, with 85% of 
the participants identifying as Christian, which may have impacted any differences.  
While only ten participants elected not to answer, their mean ACPES score was 
significantly lower than that of those identifying with a particular religion.  Larger, less 
homogeneous samples may be more consistent with other research. 
Documentation: Surrogate Decision-Makers and Advance Directives 
 The majority of patients (59.7%) in this study reported that they have formally 
asked someone to be a surrogate decision-maker (SDM) for healthcare decisions and 97% 
of those people had signed official documentation.  The majority of patients (56.9%) also 
reported having completed advance directives.  This is a much higher percentage than in 
the general population, where recent statistics show that 37% of people have completed 
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advance directives (Yadav et al., 2017).  Percentages of heart failure patients with 
advance directives range from 12.7% (Butler et al., 2015) to 41% (Dunlay, Swetz, 
Mueller, & Roger, 2012), but these results are somewhat dated.  More recently, Yadav et 
al. (2017) found that 38.2% of adults with chronic illnesses had completed advance 
directives, as opposed to only 32.7% of healthy adults.  When divided into type of 
advance directive, Yadav noted that 33.4% of all patients had appointed a surrogate 
decision-maker.  The current study again shows a significantly higher percentage of 
completion of advance directives than the literature shows.  Rather than conflicting with 
current literature, the higher percentage is likely reflective of the cardiology practice, as 
advance care planning was routinely discussed during patient appointments.  
Summary 
 Overall, the data from this study show that while heart failure stage and class 
were not significant predictors of engagement in ACP, comorbid conditions, quantified in 
the CCI, are significantly associated with engagement in ACP, with higher engagement 
seen in those with higher CCIs.  Certain demographic variables were found to be 
significantly associated as well, largely consistent with the literature, with some 
discrepancies that may be due to the limitations of this study. 
Implications for Practice 
The main hypothesis of this study was that heart failure stage or class would be 
predictive of engagement in ACP, and the data here did not support that, but there were a 
number of possible reasons for this, primarily that the cardiology practice routinely 
discussed advance care planning with patients.  Results do show that engagement may be 
able to be predicted by the presence of comorbidities, especially chronic and terminal 
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diseases.  Understanding where a patient may be on the stage of change continuum can 
help determine which type of intervention may be best received by the patient with regard 
to increasing ACP engagement.  Because the ACPES was developed based partly on the 
stages of change, higher levels of engagement generally reflect stages of change further 
along the continuum.  Thus, if a patient is determined to have a low score, he is likely to 
be in one of the earlier stages of change.  Because it would not be feasible to administer 
the ACPES to every patient, variables that are significant predictors of engagement can 
be a substitute for the engagement score.  Variables based on data that are easily located 
within the medical records, such as comorbid conditions, can be used to trigger practice 
alerts.  For example, an alert can be triggered for any patient diagnosed with a terminal 
illness such as heart failure or renal failure, or for patients with a certain number of 
chronic diseases that are not necessarily terminal.  Recently, researchers developed a Best 
Practice Alert that was triggered by the presence of Stage IV cancer (Pandya, An, 
Duberstein, Dougherty, & Smith Noel, 2018).  The Alert notified providers to discuss 
Medical Orders for Life Sustaining Treatment (MOLST).  Results showed a significant 
increase in the discussion of ACP, including MOLST and palliative care referrals.  
 In practice, healthcare providers should continue to discuss ACP with patients, 
but the interventions should be targeted toward engagement levels.  A patient with very 
few comorbidities is less likely to be engaged in ACP, and thus should receive 
interventions that are intended to familiarize the patient with ACP in general, rather than 
interventions where the end goal is a discussion of end-of-life.  At the opposite end of the 
spectrum, patients with high numbers of comorbidities are likely to be more engaged in 
the process and thus will be more receptive to interventions that are more specific and 
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aimed at the patient making decisions about healthcare goals.  Findings from this study 
indicate that targeted interventions for advance care planning may be more effective if 
based on presence of comorbid conditions and demographics rather than on stage of heart 
failure.   
Future Research 
There are many areas where ACP research is needed and can be expanded.  When 
specifically looking to the ACPES, research is needed to determine its validity in a 
variety of populations, including those who are younger and those without chronic health 
conditions.  A review of the literature shows that it has been tested only in populations 
aged 50 or older (Howard et al., 2016; Sudore et al., 2013).  Additionally, the survey is 
lengthy and would be cumbersome to administer on a routine basis.  Recent efforts to 
validate a shortened survey, however, indicate that reducing the number of questions to 
as little as four may still result in adequate assessment of engagement in ACP (Sudore et 
al., 2017).  A four-question survey is much more feasible to administer, especially to 
people with chronic health conditions. 
Future research is also needed to develop interventions that are targeted for 
certain groups of individuals.  The current study was aimed at one of the first steps in this 
process: identifying factors that affect a person’s level of engagement in ACP.  
Understanding someone’s readiness to engage in the ACP process will lead to better 
identification of the stage of change that person is in as related to ACP.  At that point, 
interventions should be targeted based on the stage of change, rather than a “one size fits 
all” intervention.  Someone who is early in the stages, such as pre-contemplation, will 
need a different intervention than someone who is in the later stages such as action 
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(Zimmerman, Olsen, & Bosworth, 2000).  Fried’s work (2010), however, noted that 
someone may be in different stages of change for different ACP behaviors, and this 
would require different interventions for each behavior, which would make it difficult to 
address via different interventions.  As an example, someone may be in the action phase 
for discussing their values and preferences with family and friends, but in pre-
contemplation for discussing it with their providers.    
Lum and colleagues (2018) recently developed a successful intervention designed 
to improve the full range ACP behaviors.  The PREPARE website uses videos and other 
behavior change techniques to address knowledge, contemplation, self-efficacy, and 
readiness with regard to all four of the domains of the ACP process (decision makers, 
quality of life, flexibility in surrogate decision making, and asking clinicians questions).  
The study also used an easy-to-read AD in order to help people complete documentation 
of their wishes.  A control group used only the easy-to-read AD.  While both 
interventions increased ACP, the PREPARE intervention resulted in nearly 100% 
engagement in the full range of ACP behaviors, including discussions with family and 
providers and documentation. 
 With regard to the differences seen in ethnicity, future research is needed to 
narrow the gap seen in engagement.  It has been theorized that this may be partially due 
to access to healthcare and trust in the system.  Regardless of the cause, there should be 
no disparities in ACP engagement based on ethnicity.  Recent research indicates that 
African-Americans may prefer informal conversations about ACP rather than the use of 
formal ADs (Carr, 2011; Gerst & Burr, 2008; Johnson, Tuchibhatla, & Tulsky, 2008; 
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Teno et al., 1997).  Based on this, some interventions are now being carried out jointly 
with churches and other faith communities (Carr & Luth, 2017).    
Study Limitations 
An important limitation of the current study is the low response rate of patients 
with Stage D heart failure, resulting in the need to combine their results with those of 
patients with Stage C heart failure.  Study findings may not be fully representative of all 
stages of heart failure due to difficulty identifying patients in Stage A and the low 
response rate from patients in Stage D.  Although the current study showed that heart 
failure stage and class were not statistically significant predictors of engagement, the 
results could change if the sample size were larger and more diverse.   
 A greater percentage of participants identified as White or Caucasian than 
African-American (56.2% and 39%, respectively).  In the general population, however, 
African-Americans are 1.5 times more likely to develop heart failure.  This discrepancy 
may be reflective of the cardiology practice, but race/ethnicity of the non-responders was 
not collected.    
Another limitation is that the participants were all recruited from one group of 
cardiologists in Cincinnati, Ohio, and may not represent the general population of 
patients with heart failure.  Additionally, the physicians at this practice routinely 
discussed advance care planning during their appointments with patients, thus potentially 
skewing the results.  The current study, having found no significant differences in 
engagement in ACP between Caucasians and African-Americans, was inconsistent with 
previous literature, which indicates that African-Americans are generally less engaged in 
ACP than Caucasians (
102 
Huang, 2016; Reynolds et al., 2008).  This may be due to the restricted sample coming 
from only one heart failure physician group.  Additionally, the physicians at the group 
routinely discussed ACP during patient office visits, which may have confounded any 
difference based on race/ethnicity in the current results. 
The modified ACPES used in this study is new and not widely used.  The 
participants in the original research were over 55 years of age with at least two chronic 
medical conditions, and later testing of the survey was also done on patients aged 50 or 
older (Howard et al., 2016).  Recent work has been aimed at making the survey more 
feasible to administer, while retaining its validity.  The ACPES was examined as 82, 55, 
34, 15, nine, and four items (Sudore et al., 2017).  The 55-, 34-, and 15-item 
modifications were found to have internal consistency and construct validity similar to 
the 82-item survey.  The smallest surveys, of nine and four items, were recommended for 
use in quality improvement settings or in clinical studies with limited resources. 
Conclusion 
 This study provides preliminary evidence demonstrating that the extent of a 
patient’s comorbidities is associated with stage of engagement in ACP.  Because the rates 
of ACP remain low despite an increased movement to address them, interventions are 
still needed to improve ACP among a variety of populations, including both healthy 
adults and those with chronic illnesses.  This study is the first step to developing such 
interventions, by identifying variables that can be used to predict a person’s level of 
engagement and stage of change, and thus develop interventions targeted at moving 
someone along the change continuum. 
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APPENDIX A: INTRODUCTION LETTER 
 
 
 
  
 This letter is to introduce Lori Catalano, RN, who is a doctoral student in the 
School of Nursing at Indiana University and has worked with me in the past.  She is 
working with me and Dr. Susan Hickman, her advisor, doing research on advance care 
planning.  We would like to invite you to assist with this project by completing two 
questionnaires which cover certain aspects of this topic.  The questionnaires should only 
take about 10 minutes for you to complete. 
 
Advance care planning is making decisions about the care you would want to receive if 
you become unable to speak for yourself.  Your decisions are based on your personal 
values, preferences, and discussions with your loved ones.  It includes talking about your 
goals and preferences for care with your family and loved ones and your healthcare 
providers.  It also includes completing official documentation, including the appointment 
of a healthcare proxy or surrogate decision maker, and the completion of living wills or 
advance directives.  Additional resources about advance care planning are provided in 
this packet should you wish to explore them after completing the questionnaires. 
 
For this study, you will be asked to complete two questionnaires.  The first one contains 
questions about your background.  The second contains questions about advance care 
planning.  Your participation is voluntary and you may skip any question that you do not 
want to answer.  When you complete the questionnaires, please place them in the 
provided postage-paid envelope and return them through U.S. mail. 
 
While there are no direct benefits to you for participating in this study, your participation 
is greatly appreciated.  As a token of appreciation, if you return the questionnaires within 
the first two weeks, you will be entered into a drawing for three $50 gift cards to a local 
grocer of your choice.  If you return the questionnaires after the first two weeks, you will 
be entered into a drawing for three $25 gift cards to a local grocer of your choice.  If you 
do not return the questionnaires within one month, your information will not be able to be 
included in the research.  To be entered in the drawing, fill out your name, address, 
telephone number, and preferred grocer on the provided index card and include it in the 
envelope when you return it. 
 
Be assured that any information provided will be treated in the strictest confidence and 
you will never be identified by name in any publication or presentation.  If you have any 
questions about this study, please call Lori Catalano, at xxx-xxx-xxxx, or Dr. Susan 
Hickman at xxx-xxx-xxxx. 
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Information about HIPAA 
 
By returning the survey and question, you are giving permission for your PHI (Protected 
Health Information) to be released from Ohio Heart & Vascular Center to the research 
team, for the specific purpose of this study.  You have the right to decide who may 
review or use your PHI.  For this study, the research team will have access to your name, 
address, birthdate, and medical record number.   
 
This permission is for the research team to access your medical records to determine your 
medical history, including your heart failure stage and other medical diagnoses.  No other 
information will be accessed from your medical records, and the information will be used 
only for this research study.   
 
You are giving permission for the following people to access your PHI for the purposes 
of this study: 
• The researchers and research staff conducting the study at Indiana University and 
IU Health 
• Principal Investigators: Susan Hickman, Lori Catalano, and Santosh Menon 
• The members and staff of the Human Subjects Office 
• The members of the Institutional Review Boards (IRB) that approve this study 
• Indiana University and/or Indiana University affiliated institutions with 
compliance and financial oversight, including but not limited to the Office of 
Research Compliance, Office of Research Administration, HIPAA Privacy and 
Security Compliance Office, General Counsel’s Office, Internal Audit, and US or 
foreign governments or agencies as required by law   
 
Efforts will be made to ensure that your PHI will not be shared with other people outside 
of the research study.  However, your PHI may be disclosed to others as required by law 
and/or to individuals or organizations that oversee the conduct of research studies, and 
these individuals or organizations may not be held to the same legal privacy standards as 
are doctors and hospitals.  Thus, the Research Team cannot guarantee absolute 
confidentiality and privacy.   
 
You have the right to not return the surveys.  If you do not return the surveys to the 
research team, then your medical history will not be shared.  Not signing the form will 
not affect my regular health care including treatment, payment, or enrollment in a health 
plan or eligibility for health care benefits.  However, not signing the form will prevent me 
from participating in the research study above.  You also have the right to review and 
obtain a copy of my personal health information collected during the study.  However, it 
may be important to the success and integrity of the study that persons who participate in 
the study not be given access until the study is complete.  The Principal Investigator has 
discretion to refuse to grant access to this information if it will affect the integrity of the 
study data during the course of the study. Therefore, your request for information may be 
delayed until the study is complete.  You may also cancel this authorization at any time.  
To do so, you must notify the Principal Investigator (Lori Catalano) for this study in 
writing at: University of Cincinnati College of Nursing, P.O. Box 210038, Cincinnati, 
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OH, 45221-0038.  If you cancel this authorization, the Research Team may still use 
information that was collected as part of the research project from the time you returned 
the survey to the date you cancel the authorization.  This is to protect the quality of the 
research results.  
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APPENDIX B: BACKGROUND QUESTIONNAIRE 
 
 
Advance Care Planning Engagement Survey 
BACKGROUND QUESTIONNAIRE 
1. What is your age? 
a. 18 – 30  
b. 31 – 40 
c. 41 – 50 
d. 51 – 60 
e. 61 – 70 
f. Over 70  
 
2. What is your gender? 
a. Male  
b. Female 
 
3. What is your race?  Circle all that apply. 
a. African American or black 
b. Caucasian or white 
c. Asian 
d. American Indian / Native Alaskan 
e. Native Hawaiian or other Pacific Islander 
f. Decline to answer 
g. Unknown 
 
4. Would you consider yourself to be Hispanic or Latino? 
a. Yes, Hispanic or Latino 
b. No, not Hispanic or Latino 
c. Decline to answer 
d. Unknown 
 
5. What is your current marital status? 
a. Single 
b. Married 
c. Widower or widowed 
d. Divorced 
e. Living with partner 
f. Decline to answer 
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6. When you consider your total household income, would you say that you are 
comfortable, have just enough to make ends meet, or do NOT have enough to 
make ends meet? 
a. Comfortable 
b. Just enough to make ends meet 
c. Do not have enough to make ends meet 
 
7. How much is your total annual household income before taxes? 
a. Under $24,999 
b. $25,000 – $49,999 
c. $50,000 – $74,999 
d. $75,000 – $99,999 
e. Over $100,000 
f. Unknown 
g. Decline to answer 
 
8. What is the highest level of education you have completed? 
a. Grammar school 
b. High school or equivalent (GED) 
c. Vocational/technical school (2 year) 
d. Some college 
e. Bachelor degree 
f. Master’s degree 
g. Doctoral degree 
h. Professional degree (JD, MD, etc.) 
i. Other 
j. Decline to answer 
 
9. Which of the following best describes where you live? 
a. Urban 
b. Suburban 
c. Rural 
 
10. What is your religious preference? 
a. Protestant 
b. Catholic 
c. Other Christian 
d. Mormon 
e. Jewish 
f. Muslim 
g. Other non-Christian religion 
h. Prefer not to answer 
i. No religion 
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11. In general, would you say your health is: 
a. Excellent 
b. Very good 
c. Good 
d. Fair 
e. Poor 
 
12. How do you prefer to make your healthcare decisions? 
a. All on your own 
b. With input from friends and family 
c. Shared decision making with doctor or other provider 
d. Have doctor make decisions for you 
 
13. How confident are you filling out medical forms? 
a. Excellent 
b. Very good 
c. Good 
d. Fair 
e. Poor 
 
14. How often do you have problems learning about your medical condition because 
of difficulty understanding written information? 
a. Almost all of the time 
b. Frequently 
c. Occasionally 
d. Rarely 
e. Never 
 
15. How often do you have someone help you read hospital materials? 
a. Almost all of the time 
b. Frequently 
c. Occasionally 
d. Rarely 
e. Never 
 
16. Have you already formally asked someone to be your medical decision maker? 
a. Yes 
b. No 
 
17. Have you signed official papers naming a person or group to make medical 
decisions for you? 
a. Yes 
b. No 
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18. If you have already asked someone to be your medical decision maker, have you 
talked with him/her about whether certain health situations would make your life 
not worth living? 
a. Yes 
b. No 
c. I have not asked someone to be my decision maker 
 
19. If you have already asked someone to be your medical decision maker, have you 
talked to him/her about how much flexibility you want to give her/him? 
a. Yes 
b. No 
c. I have not asked someone to be my decision maker 
 
20. Have you signed official papers to put your wishes about how much flexibility to 
give your decision maker in writing? 
a. Yes 
b. No 
c. I have not asked someone to be my decision maker 
 
21. Have you talked to your doctor about who you want your medical decision maker 
to be? 
a. Yes 
b. No 
 
22. Have you talked with your doctor about whether certain health situations would 
make your life not worth living? 
a. Yes 
b. No 
 
23. Have you signed official papers about your wishes for medical care if you were 
seriously ill or dying (known as a living will or advance directive)? 
a. Yes 
b. No 
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APPENDIX C: ADVANCE CARE PLANNING ENGAGEMENT SURVEY 
Advance Care Planning Engagement Survey 
Please answer the following questions based on how you feel today. 
1. How well informed are you about what makes someone a good decision maker? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly  
e. Extremely  
 
2. How well informed are you about the types of decisions that a medical decision 
maker may have to make for you in the future? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly  
e. Extremely  
 
3. How much have you thought about who you think your medical decision maker 
should be? 
a. Never 
b. Once 
c. A few times 
d. Several times 
e. A lot 
 
4. How confident are you that today you could ask someone to be your medical 
decision maker? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
 
5. How confident are you that today you could talk with your doctor about who you 
want your medical decision maker to be? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
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6. How confident are you that today you could talk with your other family and 
friends about who you want your medical decision maker to be? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
 
7. How ready are you to formally ask someone to be your medical decision maker? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
8. How ready are you to talk with your doctor about who you want your medical 
decision maker to be? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
9. How ready are you to talk to your other family and friends about who you want 
your medical decision maker to be? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
10. How ready are you to sign official papers naming a person or group of people to 
make medical decisions for you? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
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11. How confident are you that today you could talk with your medical decision 
maker about whether or not certain health situations would make your life not 
worth living? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
 
12. How confident are you that today you could talk with your doctor about whether 
or not certain health situations would make your life not worth living? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
 
13. How confident are you that today you could talk with your other family and 
friends about whether or not certain health situations would make your life not 
worth living? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely 
 
14. How ready are you to decide whether or not certain health situations would make 
your life not worth living? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
15. How ready are you to talk to your decision maker about whether or not certain 
health situations would make your life not worth living? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
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16. How ready are you to talk to your doctor about whether or not certain health 
situations would make your life not worth living? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
17. How ready are you to talk to your other family and friends about whether or not 
certain health situations would make your life not worth living? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
18. How much have you thought about talking with your other family and friends 
about the care you would want if you were very sick or near the end of life? 
a. Never 
b. Once 
c. A few times 
d. Several times 
e. A lot 
 
19. How confident are you that today you could talk with your medical decision 
maker about the care you would want if you were very sick or near the end of 
life? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
 
20. How confident are you that today you could talk with your doctor about the care 
you would want if you were very sick or near the end of life? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
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21. How confident are you that today you could talk with your other family and 
friends about the care you would want if you were very sick or near the end of 
life? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
 
22. How ready are you to decide on the medical care you would want if you were 
very sick or near the end of life? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
23. How ready are you to talk to your decision maker about the kind of medical care 
you would want if you were very sick or near the end of life? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
24. How ready are you to talk to your doctor about the kind of medical care you 
would want if you were very sick or near the end of life? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
25. How ready are you to talk to your other family and friends about the kind of 
medical care you would want if you were very sick or near the end of life? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
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26. How ready are you to sign official papers putting your wishes in writing about the 
kind of medical care you would want if you were very sick or near the end of life? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
27. How much have you thought about talking with your medical decision maker 
about how much flexibility you want to give them? 
a. Never  
b. Once 
c. A few times 
d. Several times 
e. A lot 
 
28. How confident are you that today you could talk with your doctor about how 
much flexibility you want to give your medical decision maker? 
a. Not at all  
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
 
29. How confident are you that today you could talk with your other family and 
friends about how much flexibility you want to give your medical decision 
maker? 
a. Not at all  
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
 
30. How ready are you to talk to your decision maker about how much flexibility you 
want to give them? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
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31. How ready are you to talk to your doctor about how much flexibility you want to 
give your decision maker? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
32. How ready are you to sign official papers putting your wishes in writing about 
how much flexibility to give your decision maker?  
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
33. How confident are you that today you could ask the right questions of your doctor 
to help make good medical decisions? 
a. Not at all 
b. A little 
c. Somewhat 
d. Fairly 
e. Extremely  
 
34. How ready are you to ask your doctor questions to help you make a good medical 
decision? 
a. I have never thought about it 
b. I have thought about it, but I am not ready to do it 
c. I am thinking about doing it in the next 6 months 
d. I am definitely planning to do it in the next 30 days 
e. I have already done it 
 
Please add any other information you feel is important below: 
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2011, University of Cincinnati College of Nursing and Health, Cincinnati, Ohio 
FORMAL TEACHING EXPERIENCE 
 
Courses Developed 
 
University of Cincinnati, Cincinnati, Ohio 
2019 NBSN2105 & 2107 Pathophysiology & Pharmacology I & II 
2018 NBSN2007 Pharmacology, 3 credit hours, U 
2017 NBSN3046 Biomedical Ethics, 3 credit hours, U 
2015 PMSN7024C Accelerated Care of Adults, 6 credit hours, U 
2014 PMSN7034 Care of Adults with Complex Health Problems I, 3 credit 
hours, U 
2013 NBSN1001 Introduction to Professional Nursing, 3 credit hours, U 
2012 29NURS207 Nursing Ethics and Law, 3 credit hours, U 
 
Courses Taught 
 
University of Cincinnati, Cincinnati, Ohio 
2018–2019 NBSN2007: Pharmacology (3U) 
2018 NBSN4002C: Care of Adults with Complex Health Concerns (4U) 
2017 NBSN3046: Biomedical Ethics (3U) 
2016–2018 PMSN7043C: Accelerated Complex CLINICAL (3U) 
2015–2018 NBSN2005: Pathophysiology (4U) 
2015–2019 NBSN3086: Strategies for NCLEX Preparation (3U) 
2014–2019 PMSN7024C: Accelerated Care of Adults (6U) 
2014–2017 PMSN7010C: Accelerated Assessment LAB (3U) 
2014–2015 PMSN7034: Accelerated Complex I (3U) 
2014 NBSN4002C: Care of Adults with Complex Health Concerns CLINICAL 
(3U) 
2013–2014 NBSN4065: RN-BSN Nurse as Professional Leader/Manager (3U) 
2013  PMSN7040C: Accelerated Complex II CLINICAL (3U) 
2013  PMSN7024C: Accelerated Care of Adults CLINICAL (3U) 
2013  PMSN7012: Accelerated Fundamentals CLINICAL (3U) 
2013–2014 PMSN7014: Accelerated Socialization (2U) 
2013  NBSN1001: Introduction to Professional Nursing (3U) 
2013  NBSN3001C: Care of Adults CLINICAL (3U) 
2013, 2015 PMSN7036: Accelerated Leadership (2U) 
2012–2015 NBSN2001C: Fundamental Concepts and Skills LAB (2U) 
2012–2014 NBSN4064: RN-BSN Genetics (2U) 
 2012  29NURS203: Foundations of Nursing II CLINICAL (3U) 
2012  29NURS202: Foundations of Nursing I (3U) 
2012  29NURS207: Nursing Ethics and the Law (3U) 
2012  29NURS703: Socialization to Professional Nursing (2U) 
2011  29NURS303: Care of Adults CLINICAL (3U) 
2011–2012 29NURS700: Accelerated Assessment (2U) 
2011  29NURS702: Accelerated Fundamentals of Nursing CLINICAL (3U) 
2011  29NURS204: Nursing Health Assessment LAB (2U) 
2011–2012 29NURS712: Accelerated Leadership & Management (2U) 
2011–2012 29NURS468: RN-BSN Nurse as Professional Leader and Manager (3U) 
 
 
Christ College of Nursing & Health Sciences, Cincinnati, Ohio 
2011 Medical/Surgical CLINICAL (3U)   
 
